Home Loan Servicing Solutions (HLSSF) 10-Q 16 Oct 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 16, 2014
Document And Entity Information [Abstract]	'	'
Entity Registrant Name	'HOME LOAN SERVICING SOLUTIONS, LTD.	'
Trading Symbol	'HLSS	'
Entity Central Index Key	'0001513161	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	71,016,771

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets	'	'
Cash and cash equivalents	$130,160	$87,896
Match funded advances	6,100,277	6,387,781
Notes receivable – Rights to MSRs	618,962	633,769
Loans held for investment	832,413	0
Related party receivables	26,223	70,049
Deferred tax assets	1,024	1,024
Other assets	243,286	130,153
Total assets	7,952,345	7,310,672
Liabilities	'	'
Match funded liabilities	5,545,636	5,715,622
Other borrowings	1,093,837	343,386
Dividends payable	12,783	10,653
Income taxes payable	426	682
Deferred tax liabilities	1,189	1,266
Related party payables	8,517	10,732
Other liabilities	12,685	11,884
Total liabilities	6,675,073	6,094,225
Commitments and Contingencies (See Note 18)	'	'
Equity	'	'
Equity – Ordinary shares, $.01 par value; 200,000,000 shares authorized; 71,016,771 shares issued and outstanding at September 30, 2014, and December 31, 2013	710	710
Additional paid-in capital	1,210,207	1,210,057
Retained earnings	64,773	3,513
Accumulated other comprehensive income, net of tax	1,582	2,167
Total equity	1,277,272	1,216,447
Total liabilities and equity	$7,952,345	$7,310,672

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Common stock, Par value	$0.01	$0.01
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	71,016,771	71,016,771
Common stock, shares outstanding	71,016,771	71,016,771

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue	'	'	'	'
Interest income – notes receivable – Rights to MSRs	$84,850	$78,447	$273,962	$192,106
Interest income – other	12,118	697	22,869	896
Total interest income	96,968	79,144	296,831	193,002
Related party revenue	320	491	1,721	1,458
Total revenue	97,288	79,635	298,552	194,460
Operating expenses	'	'	'	'
Compensation and benefits	1,722	2,109	5,146	4,877
Related party expenses	390	228	1,258	680
General and administrative expenses	1,802	1,275	6,242	2,654
Total operating expenses	3,914	3,612	12,646	8,211
Income from operations	93,374	76,023	285,906	186,249
Other expense	'	'	'	'
Interest expense	44,146	36,080	121,658	74,356
Total other expense	44,146	36,080	121,658	74,356
Income before income taxes	49,228	39,943	164,248	111,893
Income tax expense	14	777	14	816
Net income	$49,214	$39,166	$164,234	$111,077
Earnings per share	'	'	'	'
Basic (usd per share)	$0.69	$0.55	$2.31	$1.80
Diluted (usd per share)	$0.69	$0.55	$2.31	$1.80
Weighted average shares outstanding	'	'	'	'
Basic (shares)	71,016,771	71,016,771	71,016,771	61,812,369
Diluted (shares)	71,018,542	71,016,771	71,016,771	61,812,369
Dividends declared per share (usd per share)	$0.52	$0.45	$1.45	$1.25

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net income	$49,214	$39,166	$164,234	$111,077
Other comprehensive income (loss), before tax:	'	'	'	'
Change in the value of designated cash flow hedges	1,341	-1,592	-664	3,761
Total other comprehensive income (loss), before tax	1,341	-1,592	-664	3,761
Income tax related to items of other comprehensive income (loss):	'	'	'	'
Tax benefit (expense) on change in the value of designated cash flow hedges	-610	604	79	-1,019
Total income tax benefit (expense) related to items of other comprehensive income (loss)	-610	604	79	-1,019
Total other comprehensive income (loss), net of tax	731	-988	-585	2,742
Total comprehensive income	$49,945	$38,178	$163,649	$113,819

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Changes in Equity (USD $)	Total	Ordinary Shares	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss) net of Tax
In Thousands, except Share data, unless otherwise specified
Balance at Dec. 31, 2012	$873,379	$559	$876,657	($2,761)	($1,076)
Balance (in shares) at Dec. 31, 2012	'	55,884,718	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'
Net income	111,077	'	'	111,077	'
Other comprehensive loss, net of tax	2,742	'	'	'	2,742
Issuance of ordinary shares, net of costs (in shares)	15,132,053	15,132,053	'	'	'
Issuance of ordinary shares, net of costs	333,536	151	333,385	'	'
Declaration of cash dividends	-79,425	'	0	-79,425	'
Balance at Sep. 30, 2013	1,241,309	710	1,210,042	28,891	1,666
Balance (in shares) at Sep. 30, 2013	'	71,016,771	'	'	'
Balance at Dec. 31, 2013	1,216,447	710	1,210,057	3,513	2,167
Balance (in shares) at Dec. 31, 2013	'	71,016,771	'	'	'
Increase (Decrease) in Stockholders' Equity [Roll Forward]	'	'	'	'	'
Net income	164,234	'	'	164,234	'
Other comprehensive loss, net of tax	-585	'	'	'	-585
Issuance of ordinary shares, net of costs (in shares)	0	'	'	'	'
Stock compensation	150	'	150	'	'
Declaration of cash dividends	-102,974	'	0	-102,974	'
Balance at Sep. 30, 2014	$1,277,272	$710	$1,210,207	$64,773	$1,582
Balance (in shares) at Sep. 30, 2014	'	71,016,771	'	'	'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Changes in Equity (Parenthetical) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Stockholders' Equity [Abstract]	'	'	'	'
Declaration of cash dividends, per share	$0.52	$0.45	$1.45	$1.25

Condensed_Consolidated_Stateme4

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities	'	'
Net income	$164,234	$111,077
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Amortization of debt issuance costs	15,160	11,113
Accretion of original issue discount on other borrowings	563	197
Net accretion on Loans held for investment	-1,631	0
Share-based compensation expense	150	0
Changes in assets and liabilities:	'	'
Decrease in Match funded advances	287,504	662,977
Increase in debt service accounts	-15,806	-63,586
Decrease in related party receivables	43,826	16,989
(Decrease) increase in related party payables	-2,215	32,315
(Increase) decrease in other assets	-14,922	834
Increase in other liabilities	734	7,729
Net cash provided by operating activities	477,597	779,645
Cash flows from investing activities	'	'
Purchase of Notes receivable – Rights to MSRs	0	-387,300
Reduction in Notes receivable – Rights to MSRs	14,807	25,102
Purchase of Loans held for investment	-900,513	0
Proceeds from Loans held for investment	69,731	0
Cash used in advance financing receivables transaction	-86,206	0
Cash from reduction in advance financing receivables	1,216	0
Acquisition of advances in connection with the purchase of Residential Mortgage Assets	0	-3,492,489
Net cash used in investing activities	-900,965	-3,854,687
Cash flows from financing activities	'	'
(Repayments of) proceeds from Match funded liabilities, net	-169,986	2,496,606
Proceeds from Other borrowings	773,798	344,750
Payment of Other borrowings	-23,910	-875
Payment of debt issuance costs	-13,426	-23,025
Proceeds from issuance of ordinary shares	0	334,390
Payment of offering costs	0	-542
Payment of dividends to shareholders	-100,844	-75,478
Net cash provided by financing activities	465,632	3,075,826
Net increase in cash	42,264	784
Cash at beginning of period	87,896	76,048
Cash at end of period	130,160	76,832
Supplemental non-cash financing activities	'	'
Dividends declared but not paid	12,783	10,653
Offering costs accrued but not paid	0	312
Debt issuance costs accrued but not paid	$108	$810

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Organization
	Home Loan Servicing Solutions, Ltd. and its wholly owned subsidiaries (collectively referred to throughout as “HLSS”, “us”, “our”, “we” or the “Company”) focus on acquiring mortgage servicing rights and the related servicing advances, Loans held for investment and other residential mortgage-related assets ("Residential Mortgage Assets").
	Basis of Presentation and Use of Estimates
	We prepared the accompanying unaudited Interim Condensed Consolidated Financial Statements in conformity with the instructions of the Securities and Exchange Commission (“SEC”) to Form 10-Q for interim financial statements. In our opinion, the accompanying unaudited financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates. Material estimates that are particularly significant relate to our fair value measurements of Notes receivable – Rights to MSRs.
	Principles of Consolidation
	Our financial statements include the accounts of Home Loan Servicing Solutions, Ltd. and its wholly owned subsidiaries as well as four variable interest entities (“VIE”) of which we are the primary beneficiary. We eliminate intercompany accounts and transactions in consolidation.
	We evaluate each special purpose entity (“SPE”) for classification as a VIE. When a SPE meets the definition of a VIE and we determine that HLSS is the primary beneficiary, we include the SPE in our Interim Condensed Consolidated Financial Statements.
	Our Match funded advances are in two SPEs along with related Match funded liabilities (the "Match Funded Advances SPEs"). We determined that these SPEs are VIEs of which we are the primary beneficiaries. The accounts of these SPEs are included in our Interim Condensed Consolidated Financial Statements.
	Match funded advances on loans serviced for others result from our transfers of residential loan servicing advances to SPEs in exchange for cash. The SPEs issue debt supported by collections on the transferred advances. We made these transfers under the terms of our advance facility agreements. These transfers do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred advances on our Interim Condensed Consolidated Balance Sheet as Match funded advances and the related liabilities as Match funded liabilities. We use collections on the Match funded advances pledged to the SPEs to repay principal and to pay interest and the expenses of the SPEs. Holders of the debt issued by the SPEs can look only to the assets of the entity itself for satisfaction of the debt and have no recourse against HLSS.
	Our Loans held for investment are in two SPEs along with related Other borrowings (the "Mortgage Loans SPEs"). We determined that these SPEs are VIEs of which we are the primary beneficiaries. The accounts of these SPEs are included in our Interim Condensed Consolidated Financial Statements.
	Loans held for investment are transferred to SPEs in exchange for cash, and the SPEs issue debt collateralized by these loans. These transfers do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred loans on our Interim Condensed Consolidated Balance Sheet as Loans held for investment and the related liabilities as Other borrowings. We use collections on the Loans held for investment pledged to the SPEs to repay principal and to pay interest and the expenses of the SPEs. Holders of the debt issued by the SPEs can look beyond the assets of the SPEs for satisfaction of the debt and therefore have recourse against HLSS. It is our expectation that the cash flows of the SPEs will be sufficient to meet all claims of the debt holders. HLSS is responsible for making any principal or interest payments to the debt holders not covered by the cash flows of the SPEs.
	The following tables summarize the assets and liabilities of our consolidated SPEs at the dates indicated:
	At September 30, 2014		Match Funded Advance SPEs		Mortgage Loans SPEs		Total
	Match funded advances		$	6,100,277	$	—	$	6,100,277
	Loans held for investment		—		832,413		832,413
	Related party receivables (1)		15,352		343		15,695
	Other assets (2)		126,199		108,324		234,523
	Total assets		$	6,241,828	$	941,080	$	7,182,908
	Match funded liabilities		$	5,545,636	$	—	$	5,545,636
	Other borrowings (3)		—		726,565		726,565
	Related party payables		—		134		134
	Other liabilities		4,937		1,900		6,837
	Total liabilities		$	5,550,573	$	728,599	$	6,279,172
	At December 31, 2013		Match Funded Advance SPEs		Mortgage Loans SPEs		Total
	Match funded advances		$	6,387,781	$	—	$	6,387,781
	Loans held for investment		—		—		—
	Related party receivables (1)		60,239		—		60,239
	Other assets (2)		119,902		—		119,902
	Total assets		$	6,567,922	$	—	$	6,567,922
	Match funded liabilities		$	5,715,622	$	—	$	5,715,622
	Other borrowings (3)		—		—		—
	Related party payables		—		—		—
	Other liabilities		4,673		—		4,673
	Total liabilities		$	5,720,295	$	—	$	5,720,295
	-1	Related party receivables principally include Match funded advance collections that were in-transit to pay down our Match funded liabilities as of each presented period. See Note 17 for more information about our Related party receivables.
	-2	Other assets principally include debt service accounts, debt issuance costs and advances we financed as part of asset acquisitions. See Note 6 for more information about our Other assets.
	-3	Other borrowings include the carrying value of our borrowings to acquire Loans held for investment. See Note 8 for more information about our Other borrowings.
	Loans Held for Investment and Related Accrued Income
	Loans held for investment consist of residential mortgage loans acquired from others. The Company does not originate loans. Each acquired loan is evaluated at acquisition to determine if the loan is impaired at the time of acquisition.
	The Company evaluates purchased loans that are not deemed impaired upon acquisition in accordance with the provisions of Accounting Standards Codification ("ASC") ASC 310-20, Receivables - Nonrefundable Fees and Other Costs. The fair value premium or discount on these loans is amortized into interest income over the weighted average life of the loans using a level yield method. Interest income is accrued at the rate specified in the individual loan agreements based on the unpaid principal balance ("UPB").
	For loans accounted for under ASC 310-20, we periodically evaluate whether all contractual payments will be collected as scheduled according to the contractual terms. We incorporate the probable recovery of such payments resulting from Federal Housing Administration ("FHA") insurance in this analysis, as applicable. We evaluate these loans on a periodic basis to ensure the carrying value is the lower of cost or fair value. We recognized no loan impairments for the three and nine months ended September 30, 2014.
	We periodically evaluate whether our Loans held for investment, including individual loans and pools of loans, should be placed on non-accrual status. All of our Loans held for investment remained on accrual status for the three and nine months ended September 30, 2014.
	The Company evaluates purchased impaired loans in accordance with the provisions of ASC 310-30, Receivables - Loans and Debt Securities Acquired with Deteriorated Credit Quality. Purchased loans are considered impaired if there is evidence of credit deterioration since origination and if it is probable that not all contractually required payments will be collected.
	For impaired loans accounted for under ASC 310-30, we continue to estimate cash flows expected to be collected, adjusted for expected prepayments, on pools of loans sharing common risk characteristics which are treated in the aggregate when applying various valuation techniques. We evaluate at each balance sheet date whether the present value of our pools of loans determined using the effective interest rates has decreased and, if so, recognize a provision for loan loss. For any increases in cash flows expected to be collected, we reduce any loss provisions previously recorded, if applicable, and then adjust the amount of accretable yield recognized on a prospective basis over the pool’s remaining life. We recognized no provisions for loan loss nor any adjustments to the amount of the accretable yield for the three and nine months ended September 30, 2014.
	Recent Accounting Pronouncements
	Accounting Standards Update (“ASU”) 2013-11. This ASU provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit exists. Previously, there was diversity in practice, and this ASU is expected to eliminate that diversity in practice. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. Our adoption of this standard effective January 1, 2014, did not have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-04. The objective of this ASU is to reduce diversity by clarifying when an in substance repossession or foreclosure occurs; that is, when a creditor should be considered to have received physical possession of residential real estate property collateralizing a consumer mortgage loan such that the loan receivable should be derecognized and the real estate property recognized. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. We do not expect these amendments to have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-06. This ASU provides technical corrections and improvements to Accounting Standards Codification glossary terms. Our adoption of this standard, effective March 14, 2014, did not have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-14. The amendments in this ASU require that certain government-guaranteed mortgage loans, including those guaranteed by the FHA, be derecognized and that a separate other receivable be recognized upon foreclosure if certain conditions are met. Upon foreclosure on loans that meet these criteria, a separate receivable should be recorded based on the amount of the loan balance expected to be recovered from the guarantor. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. We do not expect these amendments to have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-15. The amendments in this ASU provide guidance in GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The amendments in this update are effective for fiscal years and interim periods ending after December 15, 2016. We do not expect these amendments to have a material impact on our Interim Condensed Consolidated Financial Statements.
	Certain disclosures included in the Company’s Annual Report are not required to be included on an interim basis in the Company’s Quarterly Reports on Forms 10-Q. The Company has condensed or omitted these disclosures. Therefore, this Form 10-Q should be read in conjunction with the Company’s amended Annual Report on Form 10-K/A for the year ended December 31, 2013, which was filed with the SEC on August 18, 2014 (the "2013 Form 10-K/A").

Asset_Acquisitions

Asset Acquisitions	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Asset Acquisitions	'
	ASSET ACQUISITIONS
	On March 3, 2014, we acquired Government National Mortgage Association ("GNMA") loans with UPB of $549,411 from Ocwen Financial Corporation (together with its subsidiaries, collectively "Ocwen"). Because these loans earn interest at a rate that is higher than current market rates, the loans were purchased at a premium to par, resulting in a total purchase price of $556,618. We amortize the purchase price premium over the expected life of the portfolio using the interest method of accounting. These loans are insured by the FHA, making the collectability of the entire balance of these loans reasonably assured. We account for these GNMA loans as Loans held for investment.
	Ocwen initially acquired these loans through the GNMA early buy-out (“EBO”) program, which allows servicers of federally insured or guaranteed loans to buy delinquent loans from the applicable loan securitization pools. We also financed the GNMA EBO advances related to the GNMA EBO loans, and we account for this arrangement as a financing transaction because Ocwen retained title and all other rights and rewards associated with the GNMA EBO advances. Collectively, the purchase of GNMA EBO loans and financing of the related advances are referred to as the “GNMA EBO Transaction.”
	Our GNMA EBO loans are in a Mortgage Loans SPE along with the related financing facility (the "EBO Facility"), which is more fully described in Note 8. The accounts of this SPE are included in our Interim Condensed Consolidated Financial Statements. These transfers to the SPE do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred GNMA EBO loans on our Interim Condensed Consolidated Balance Sheet as Loans held for investment and the related liabilities as Other borrowings. We use collections on the GNMA EBO loans pledged to the SPE to repay principal and to pay interest and the expenses of the entity. The holders of the debt issued by this SPE can look beyond the assets of the SPE for satisfaction of the debt and therefore have recourse against HLSS. It is our expectation that, since our GNMA EBO loans are insured by the FHA, the cash flows of this SPE will be sufficient to meet all claims of the debt holders. HLSS is responsible for making any principal or interest payments to the debt holders not covered by the cash flows of the SPE.
	On June 27, 2014, HLSS purchased a portfolio of re-performing mortgage loans ("RPLs") from a third party seller with a UPB of $396,939 (the "RPL Transaction"). Because RPLs have historically experienced default conditions, are not insured by any agency and earn interest at a rate that is lower than current market rates, the loans were purchased at a discount of par equivalent to thirty percent of UPB, resulting in a total purchase price of $276,248. In accordance with ASC 310-30, we will recognize the excess cash flows over the purchase price as interest income on a level yield basis.
	On July 31, 2014, HLSS completed a follow-on purchase of RPLs from a third party seller with a UPB of $92,908 (the "RPL Follow-on Transaction") under substantially the same terms and conditions as the RPL Transaction. The total purchase price was $67,647, and we will recognize the excess cash flows over the purchase price as interest income on a level yield basis in accordance with ASC 310-30.
	Ocwen serviced the RPLs prior to the RPL Transaction and the RPL Follow-on Transaction, and Ocwen remains the servicer subsequent to the acquisitions.
	Our RPLs are in a Mortgage Loans SPE along with the related financing facility (the “RPL Facility”), which is more fully described in Note 8. The accounts of this SPE are included in our Interim Condensed Consolidated Financial Statements. The transfers to the SPE do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financing and classify the transferred RPLs on our Interim Condensed Consolidated Balance Sheet as Loans held for investment and the related liabilities as Other borrowings. We use collections on the RPLs pledged to the SPE to repay principal and to pay interest and the expenses of the entity. The holders of the debt issued by this SPE can look beyond the assets of the SPE for satisfaction of the debt and therefore have recourse against HLSS. It is our expectation that the cash flows of this SPE will be sufficient to meet all claims of the debt holders. HLSS is responsible for making any principal or interest payments to the debt holders not covered by the cash flows of the SPE.
	The following table summarizes the purchase price of assets we acquired during the nine months ended September 30, 2014 and reconciles the cash used to acquire such assets:
	GNMA EBO loans purchase price (1)	$	556,618
	RPL purchase price (1)	276,248
	RPL follow-on purchase (1)	67,647
	Total cash required	$	900,513
	Sources:
	Cash on hand	$	154,743
	Other borrowings	745,770
	Total cash used	$	900,513
	-1	The cash used to purchase these assets is shown within “Purchase of loans held for investment” of the Interim Condensed Consolidated Statement of Cash Flows.
	During the nine months ended September 30, 2013, we executed three asset purchases from Ocwen wherein we used cash on hand and Match funded liabilities to purchase the following:
	•	The contractual right to receive the servicing fees related to mortgage servicing rights with UPB of approximately $109.8 billion, which we account for as Notes receivable - Rights to MSRs, and
	•	The outstanding servicing advances associated with the related pooling and servicing agreements.
	The following table summarizes the purchase price of the assets we acquired from Ocwen during the nine months ended September 30, 2013 and reconciles the cash used to acquire such assets:
	Notes receivable – Rights to MSRs	$	388,472
	Match funded advances (1)	3,489,907
	Purchase price, as adjusted	3,878,379
	Cash paid to settle previous post-closing adjustments	1,410
	Total cash required	$	3,879,789
	Sources:
	Cash on hand	$	739,597
	Match funded liabilities	3,140,192
	Total cash used	$	3,879,789
	-1	The cash used to purchase these assets is shown within the “Acquisition of advances in connection with the purchase of Residential Mortgage Assets” of the Interim Condensed Consolidated Statement of Cash Flows.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	FAIR VALUE OF FINANCIAL INSTRUMENTS
	We estimate fair value based on a hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assessment of the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The fair value hierarchy prioritizes the inputs to valuation techniques into three broad levels and gives the highest priority to Level 1 inputs and the lowest to Level 3 inputs.
	The three broad categories are:
	•	Level 1: Quoted prices in active markets for identical assets or liabilities;
	•	Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument; and
	•	Level 3: Unobservable inputs for the asset or liability.
	Where available, we utilize quoted market prices or observable inputs rather than unobservable inputs to determine fair value. We classify assets and liabilities in their entirety based on the lowest level of input that is significant to the fair value measurement.
	We describe the methodologies that we use and key assumptions that we make to assess the fair value of instruments in more detail below.
	Notes Receivable – Rights to MSRs
	We established the value of the Notes receivable – Rights to MSRs based on appraisals prepared by independent valuation firms. These appraisals are prepared on a quarterly basis. Significant inputs into the valuation include the following:
	•	Discount rates reflecting the risk of earning the future income streams from the Notes receivable – Rights to MSRs ranging from 15% to 22%;
	•	Interest rate used for calculating the cost of financing servicing advances of 1-Month LIBOR plus 3.50%;
	•	Mortgage loan prepayment projections ranging from 12% to 28% of the related mortgage lifetime projected prepayment rate; and
	•	Delinquency rate projections ranging from 15% to 35% of the aggregate unpaid balance of the underlying mortgage loans.
	The independent valuation firms reviewed the collateral attributes and the historical payment performance of the underlying mortgage servicing portfolio and compared them with similar mortgage servicing portfolios and with standard industry mortgage performance benchmarks to arrive at the assumptions set forth above. The selected collateral attributes and performance comparisons utilized were the voluntary prepayment performance, delinquency and foreclosure performance, operational cost comparison, average loan balance, weighted average coupon and note rate distribution, loan product type classification, geographic distribution and servicing advance behavior.
	The unobservable inputs that have the most significant effect on the fair value of Notes receivable – Rights to MSRs are the mortgage loan prepayment rate projections and delinquency rate projections; however, any significant increase (decrease) in discount rates, interest rates, mortgage loan prepayment projections or delinquency rate projections, each in isolation, would result in a substantially lower (higher) valuation.
	Derivative Financial Instruments
	Our derivatives are not exchange-traded, and therefore quoted market prices or other observable inputs are not available. The fair value of our interest rate swap agreements is based on certain information provided by third-party pricing sources. Third-party valuations are derived from proprietary models based on inputs that include yield curves and contractual terms such as fixed interest rates and payment dates. We have not adjusted the information obtained from the third-party pricing sources; however, we review this information to ensure that it provides a reasonable basis for estimating fair value. Our review is designed to identify information that appears stale, information that has changed significantly from the prior period and other indicators that the information may not be accurate. We determined that potential credit and counterparty risks had an immaterial impact on the valuation of our derivatives. See Note 11 for additional information on our derivative financial instruments.
	The following tables present assets by level within the fair value hierarchy that are measured at fair value on a recurring basis:
	At September 30, 2014:		Fair Value				Level 1				Level 2				Level 3
	Measured at fair value on a recurring basis:
	Assets:
	Notes receivable – Rights to MSRs		$	618,962			$	—			$	—			$	618,962
	Derivative financial instruments		2,871				—				—				2,871
	Total assets		$	621,833			$	—			$	—			$	621,833
	Liabilities:
	Derivative financial instruments		$	229			$	—			$	—			$	229
	Total liabilities		$	229			$	—			$	—			$	229
	At December 31, 2013:		Fair Value				Level 1				Level 2				Level 3
	Measured at fair value on a recurring basis:
	Assets:
	Notes receivable – Rights to MSRs		$	633,769			$	—			$	—			$	633,769
	Derivative financial instruments		3,835				—				—				3,835
	Total assets		$	637,604			$	—			$	—			$	637,604
	Liabilities:
	Derivative financial instruments		$	529			$	—			$	—			$	529
	Total liabilities		$	529			$	—			$	—			$	529
	No transfers between levels occurred during the three and nine months ended September 30, 2014, and September 30, 2013.
	The following tables present reconciliations of the fair value and changes in fair value of our Level 3 assets and liabilities that we measure at fair value on a recurring basis:
			2014								2013
	For the three months ended September 30,		Notes receivable – Rights to MSRs				Derivative				Notes receivable – Rights to MSRs				Derivative
							Financial								Financial
							Instruments								Instruments
	Beginning balance		$	629,579			$	1,301			$	440,322			$	4,277
	Purchases and reductions:
	Purchases		—				—				239,850				—
	Reductions		(10,617		)		—				(17,763		)		—
			(10,617		)		—				222,087				—
	Changes in fair value :
	Included in net income (1)		—				—				(2,588		)		—
	Included in other comprehensive income (2)		—				1,341				—				(1,592		)
			—				1,341				(2,588		)		(1,592		)
	Transfers in or out of Level 3		—				—				—				—
	Ending balance		$	618,962			$	2,642			$	659,821			$	2,685
			2014								2013
	For the nine months ended September 30,		Notes receivable – Rights to MSRs				Derivative				Notes receivable – Rights to MSRs				Derivative
							Financial								Financial
							Instruments								Instruments
	Beginning balance		$	633,769			$	3,306			$	296,451			$	(1,076	)
	Purchases and reductions:
	Purchases		—				—				388,472				—
	Reductions		(14,807		)		—				(25,102		)		—
			(14,807		)		—				363,370				—
Changes in fair value :
Included in net income (1)		—				—				—				—
Included in other comprehensive income (2)		—				(664		)		—				3,761
		—				(664		)		—				3,761
Transfers in or out of Level 3		—				—				—				—
Ending balance		$	618,962			$	2,642			$	659,821			$	2,685
-1	At each reporting date, we determine the fair value of our Notes receivable – Rights to MSRs and adjust the carrying value to this amount, and these changes in fair value are included in Interest income in the Interim Condensed Consolidated Statements of Operations. See Note 12 for additional information regarding our Interest income.
-2	These pre-tax gains (losses) are attributable to derivatives still held at September 30, 2014, and September 30, 2013, respectively.
The following table shows the effect on the fair value of the Notes receivable – Rights to MSRs assuming adverse changes to certain key assumptions used in valuing these assets at September 30, 2014, and December 31, 2013:
	Discount Rate				Prepayment Speeds				Delinquency Rates
	100 bps adverse change				10% adverse change				10% adverse change
At September 30, 2014:
Notes receivable – Rights to MSRs	$	(11,702	)		$	(22,468	)		$	(65,064	)
	Discount Rate				Prepayment Speeds				Delinquency Rates
	100 bps adverse change				10% adverse change				10% adverse change
At December 31, 2013:
Notes receivable – Rights to MSRs	$	(12,988	)		$	(22,537	)		$	(72,560	)
This sensitivity analysis above assumes a change is made to one key input while holding all other inputs constant. As many of these inputs are correlated, a change in one input will likely impact other inputs, which would ultimately impact the overall valuation.
The following table provides additional quantitative information on our significant inputs used for valuing our Notes receivable – Rights to MSRs as of September 30, 2014, and December 31, 2013, respectively:
At September 30, 2014:
Asset	Unobservable Input		Low			High			Weighted Average
Notes receivable – Rights to MSRs	Discount Rate		15	%		22	%		19	%
	Prepayment Speeds		12	%		28	%		18	%
	Delinquency Rates		15	%		35	%		25	%
At December 31, 2013:
Asset	Unobservable Input		Low			High			Weighted Average
Notes receivable – Rights to MSRs	Discount Rate		15	%		22	%		20	%
	Prepayment Speeds		12	%		28	%		19	%
	Delinquency Rates		15	%		35	%		25	%
Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value at the dates indicated:
	September 30, 2014				September 30, 2014				December 31, 2013				December 31, 2013
	Carrying Value				Fair Value				Carrying Value				Fair Value
Financial assets:
Match funded advances	$	6,100,277			$	6,100,277			$	6,387,781			$	6,387,781
Loans held for investment	832,413				832,413				—				—
Total financial assets	$	6,932,690			$	6,932,690			$	6,387,781			$	6,387,781
Financial liabilities:
Match funded liabilities	$	5,545,636			$	5,545,596			$	5,715,622			$	5,700,934
Other borrowings	1,093,837				1,091,443				343,386				346,391
Total financial liabilities	$	6,639,473			$	6,637,039			$	6,059,008			$	6,047,325
Match Funded Advances
The carrying value of our Match funded advances approximates fair value. This is because our Match funded advances have no stated maturity, generally are realized within a relatively short period of time and do not bear interest. The fair value measurements for Match funded advances are categorized as Level 3.
Loans Held for Investment
The fair value estimate of these loans was determined by using internal cash flow models that require us to make assumptions regarding various inputs, including default rates, delinquency rates, interest rates and prepayment speeds. Additionally, we make assumptions related to severity for our RPLs. The fair value measurements for Loans held for investment are categorized as Level 3.
Match Funded Liabilities
Match funded liabilities include various series of term notes, variable funding notes and other fixed rate liabilities. The fair value estimate of the Company’s term notes and other fixed rate liabilities was determined by using broker quotes. We concluded that no adjustments were required to the quoted prices. The level of trading, both in number of trades and amount of term notes traded, is at a level that the Company believes broker quotes to be a reasonable representation of the current fair market value of the term notes. All other Match funded liabilities are short term in nature, and the carrying value generally approximates the fair value. The fair value measurements for Match funded liabilities are categorized as Level 3.
Other Borrowings
Other borrowings include a senior secured term loan facility, EBO Facility, RPL Facility and a servicing advance note facility (the "Note Facility"). The fair value estimate of the senior secured term loan facility was determined by using broker quotes. We concluded that no adjustments were required to the quoted price. Trading is at a level that the Company believes broker quotes to be a reasonable representation of the current fair market value of this facility. The EBO Facility, the RPL Facility and the Note Facility are short term in nature, and the carrying values generally approximate the fair values. The fair value measurements for these facilities are categorized as Level 3.

Match_Funded_Advances

Match Funded Advances	9 Months Ended
	Sep. 30, 2014
Transfers and Servicing [Abstract]	'
Match Funded Advances	'
	MATCH FUNDED ADVANCES
	Match funded advances on residential loans are comprised of the following at the dates indicated:
		September 30,		December 31,
		2014		2013
	Principal and interest advances	$	2,584,899	$	2,632,092
	Taxes and insurance advances	2,639,700		2,723,390
	Corporate advances	875,678		1,032,299
		$	6,100,277	$	6,387,781

Loans_Held_for_Investment

Loans Held for Investment	9 Months Ended
	Sep. 30, 2014
Investments, Debt and Equity Securities [Abstract]	'
Loans Held for Investment	'
	LOANS HELD FOR INVESTMENT
	Our Loans held for investment relate to GNMA EBO loans and RPLs, which are our only classes of Loans held for investment.
		30-Sep-14				31-Dec-13
	GNMA EBO loans	$	490,454			$	—
	RPLs	341,959				—
	Loans held for investment	$	832,413			$	—
	Upon acquisition, the Company reviews Loans held for investment to determine if there is evidence of credit deterioration since origination in accordance with the provisions of ASC 310-30, Loans and Debt Securities Acquired with Deteriorated Credit Quality. Any loan acquired is considered impaired if there is evidence of credit deterioration since origination and if it is probable that not all contractually required payments will be collected.
	We account for acquired Loans held for investment that are not deemed to be impaired at acquisition under ASC 310-20, Receivables - Nonrefundable Fees and Other Costs.
	GNMA EBO Loans
	We account for our GNMA EBO loans under ASC 310-20, Receivables - Nonrefundable Fees and Other Costs. In accordance with ASC 310-20-30-5, these loans are recorded at the UPB plus a purchase premium, which is the amount we paid to purchase these loans. The purchase premium is amortized into interest income using the interest method of accounting. These loans are FHA insured, making the collectability of the entire balance reasonably assured. We evaluate whether all contractual payments will be collected as scheduled according to contractual terms, including the probable recovery of such payments from FHA insurance. There were no allowances for loan losses related to the GNMA EBO loans at September 30, 2014.
	See Note 2, Asset Acquisitions, for further discussion the GNMA EBO Transaction.
	RPLs
	We account for our RPLs under ASC 310-30, Loans and Debt Securities Acquired with Deteriorated Credit Quality. The Company evaluated all of the loans purchased in the RPL Transaction in accordance with the provisions of ASC 310-30, and all RPLs were deemed to be impaired loans at acquisition. The RPLs are not insured against loss, and the borrowers, all of which have been previously delinquent, may be more likely to be in economic distress, to have become unemployed or bankrupt or to otherwise be unable or unwilling to make payments when due. Also, a portion of these loans feature future step-ups in the required payment.
	The RPLs were grouped into pools based on common risk characteristics, and the pools were recorded at their estimated fair values which incorporated estimated credit losses at the acquisition date. The RPL pools are systematically reviewed by the Company to determine the risk of losses that may exceed those identified at the time of the acquisition. No individual RPLs were classified as nonperforming assets at September 30, 2014 as the loans are accounted for on a pooled basis, and the pools are considered to be performing. No RPL pools evaluated by the Company were determined to have experienced impairment in the estimated credit quality or cash flows since acquisition.
	The amount of the estimated cash flows expected to be received from the RPL pools in excess of the fair values recorded for the RPL pools is referred to as the accretable yield. The accretable yield is recognized as interest income over the estimated lives of the RPL pools. To date, the Company has made no adjustments to the accretable yield.
	Changes in the carrying amount of the accretable yield for RPL pools were as follows for the three and nine months ended September 30, 2014:
			Three months ended September 30, 2014							Nine months ended September 30, 2014
			Accretable Yield				Carrying Amount			Accretable Yield			Carrying Amount
	Beginning balance		$	146,726			$	275,838		$	—		$	—
	Additions		31,658				67,647			178,543			343,895
	Accretable yield adjustments		—				—			—			—
	Accretion		(4,600		)		4,600			(4,759		)	4,759
	Payments and other reductions, net		—				(6,126		)	—			(6,695		)
	Ending balance		$	173,784			$	341,959		$	173,784		$	341,959
	The outstanding balance of RPLs, including outstanding principal, interest, fees, penalties and other amounts due, was $443.3 million at September 30, 2014.
	At the acquisition date of June 27, 2014, the loans acquired in the RPL Transaction had contractually required payments receivable of $622.1 million and a fair value of $276.2 million. The cash flows expected to be collected were $423.1 million at the acquisition date.
	At the acquisition date of July 31, 2014, the loans acquired in the RPL Follow-on Transaction had contractually required payments receivable of $144.8 million and a fair value of $67.6 million. The cash flows expected to be collected were $99.5 million at the acquisition date.
	See Note 2, Asset Acquisitions, for further discussion the RPL Transaction and the RPL Follow-on Transaction.

Other_Assets

Other Assets	9 Months Ended
	Sep. 30, 2014
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]	'
Other Assets	'
	OTHER ASSETS
	Other assets consisted of the following at the dates indicated:
		September 30,		December 31,
		2014		2013
	Debt service accounts (1)	$	119,716	$	103,910
	Advance financing receivables (2)	84,990		—
	Debt issuance costs (3)	19,539		21,165
	Accrued interest income (4)	14,812		—
	Interest-earning collateral deposits (5)	1,075		1,075
	Derivative financial instruments (6)	2,871		3,835
	Other	283		168
		$	243,286	$	130,153
	-1	Under our advance funding facilities, we are contractually required to remit collections of Match funded advances to the trustee within two days of receipt. We do not use the collected funds to reduce the related Match funded liabilities until the payment dates specified in the indenture. The balance also includes amounts that we set aside to provide for possible shortfalls in the funds available to pay certain expenses and interest. Lastly, this balance includes collections on our Loans held for investment of $7,672, which will be used to pay down a portion of our Other borrowings on the first funding date following quarter end.
	-2	We provided financing to Ocwen for servicing advances. We receive interest income at a rate of 1-Month LIBOR plus a spread ranging from 450 bps to 550 bps.
	-3	Debt issuance costs relate to Match funded liabilities and Other borrowings. We amortize these costs to the earlier of the scheduled amortization date, contractual maturity date or prepayment date of the debt.
	-4	Accrued interest income represents interest earned but not yet collected on our Loans held for investment.
	-5	Interest-earning collateral deposits represent cash collateral held by our counterparty as part of our interest rate swap agreements.
	-6	See Notes 3 and 11 for more information regarding our use of derivatives.

Match_Funded_Liabilities

Match Funded Liabilities	9 Months Ended
	Sep. 30, 2014
Text Block [Abstract]	'
Match Funded Liabilities	'
	MATCH FUNDED LIABILITIES
	Match funded liabilities are comprised of the following at the dates indicated:
								Balance Outstanding
	Borrowing Type (1)		Interest Rate	Maturity	Amortization Date (3)	Unused Borrowing Capacity (4)		September 30, 2014 (5)		December 31, 2013
			-2	-3
	Series 2012 T2 Term Notes		199 – 494 bps	Oct. 2045	Oct. 2015	$	—	$	450,000	$	450,000
	Series 2013 T1 Term Notes		90 – 249 bps	Jan. 2044	Jan. 2014	—		—		650,000
	Series 2013 T1 Term Notes		150 – 323 bps	Jan. 2046	Jan. 2016	—		350,000		350,000
	Series 2013 T1 Term Notes		229 – 446 bps	Jan. 2048	Jan. 2018	—		150,000		150,000
	Series 2013 T2 Term Notes		115 – 239 bps	May-44	May-15	—		375,000		375,000
	Series 2013 T3 Term Notes		179 – 313 bps	May-46	May-17	—		475,000		475,000
	Series 2013 T4 Term Notes		118 – 232 bps	Aug. 2044	Aug. 2014	—		—		200,000
	Series 2013 T5 Term Notes		198 – 331 bps	Aug. 2046	Aug. 2016	—		200,000		200,000
	Series 2013 T6 Term Notes		129 – 223 bps	Sep. 2044	Sep. 2014	—		—		350,000
	Series 2013 T7 Term Notes		198 – 302 bps	Nov. 2046	Nov. 2016	—		300,000		300,000
	Series 2014 T1 Term Notes		124 – 229 bps	Jan. 2045	Jan. 2015	—		600,000		—
	Series 2014 T2 Term Notes		222 – 311 bps	Jan. 2047	Jan. 2017	—		200,000		—
	Series 2014 T3 Term Notes		281 bps	Jun. 2048	Jun. 2018	—		363,000		—
	Series 2012 VF 1 Notes (6)		1-Month LIBOR + 110 – 340 bps	Aug. 2045	Aug. 2015	165,400		534,600		469,050
	Series 2012 VF 2 Notes (6)		1-Month LIBOR + 110 – 340 bps	Aug. 2045	Aug. 2015	165,400		534,600		469,050
	Series 2012 VF 3 Notes (6)		1-Month LIBOR + 110 – 340 bps	Aug. 2045	Aug. 2015	165,400		534,600		469,050
	Series 2013 VF 1 Notes (7)		1-Month LIBOR + 150 - 245 bps	Feb. 2045	Feb. 2015	71,164		478,836		514,972
	Class A Term Money Market Fund Note		1-Month LIBOR + 20 bps	Sep. 2014	Jan. 2014	—		—		265,000
	Class B Term Money Market Fund Note		275 bps	Sep. 2044	Sep. 2014	—		—		28,500
						$	567,364	$	5,545,636	$	5,715,622
	-1	Each term note and variable funding note issuance has four classes, an A, B, C, and D class, with the exception of the Series 2014 T3 Term Notes which have only an A and B class. The Series 2014 T3 Class B Term Notes may be exchanged for notes in three separate classes: BX, CX and DX.
	-2	The weighted average interest rate at September 30, 2014, was 1.80%. We pay interest monthly.
	-3	The amortization date is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the due date for all outstanding balances. After the amortization date, all collections that represent the repayment of Match funded advances pledged to the facilities must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.
	-4	Our unused borrowing capacity is available to us if we have additional eligible collateral to pledge and meet other borrowing conditions. We pay a 0.50% or 0.625% fee on the unused borrowing capacity, which varies by facility.
	-5	On January 17, 2014, we completed the issuance of $600,000 of one-year and $200,000 of three-years term notes. On June 18, 2014, we completed the issuance of $400,000 of four-year term notes, of which we retained $37,000.
	-6	On July 16, 2014, we entered into agreements to extend the amortization dates of our Series 2012 variable funding notes to August 28, 2015.
	-7	On February 14, 2014, the Series 2013 variable funding notes were amended to extend the amortization and maturity dates by one year and to reduce the interest rate spreads compared to December 31, 2013.
	Analysis of Borrowing by Expected Maturity (1):
	Year of Expected Maturity Date	As of September 30, 2014
	2014	$	—
	2015	3,507,636
	2016	850,000
	2017	675,000
	2018 and thereafter	513,000
	Total	$	5,545,636
	-1	The expected maturity date is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.

Other_Borrowings

Other Borrowings	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Other Borrowings	'
	OTHER BORROWINGS
	Other borrowings consisted of the following at the dates indicated:
		September 30, 2014		December 31, 2013
	Senior secured term loan facility (1)	$	341,324	$	343,386
	EBO Facility (2)	452,258		—
	RPL Facility (3)	274,306		—
	Note Facility (4)	25,949		—
		$	1,093,837	$	343,386
	-1	On June 27, 2013, we entered into a $350,000 senior secured term loan facility, which was issued at a discount to par. The senior secured term loan facility has a maturity date of June 27, 2020 and an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor. As of September 30, 2014, the interest rate on our senior secured term loan facility was 4.50%.
	-2	On March 3, 2014, we entered into the EBO Facility to finance the purchase of our GNMA EBO loans. The facility has a maturity date of March 2, 2015 and an interest rate of 1-Month LIBOR plus 305 bps.
	-3	On June 26, 2014, we entered into the RPL Facility to finance the purchase of our RPLs. The facility has a maturity date of December 26, 2014 and an interest rate of 1-Month LIBOR plus 250 bps.
	-4	On June 24, 2014, we entered into the Note Facility to partially finance the purchase of $37,000 of notes retained as part of the Series 2014 T3 Term Note issuance on June 18, 2014. The Note Facility matures monthly with a next maturity date of October 23, 2014. The Note Facility has an interest rate of 1-Month LIBOR plus 115 bps.
	The weighted average interest rate for our Other borrowings was 3.43% as of September 30, 2014.
	Analysis of Other Borrowing by Expected Repayment Date (1):
	Year of Expected Payment Date	As of September 30, 2014
	2014	$	301,130
	2015	455,758
	2016	3,500
	2017	3,500
	2018 and thereafter	334,250
	Total (2)	$	1,098,138
	-1	The EBO Facility, the RPL Facility and the Note Facility expected payment dates are based on the current outstanding balance and maturity date of these facilities.
	-2	The total expected payments include the full face value of the senior secured term loan, which has a current ordinary issuance discount balance of $4,301.

Ordinary_Shares

Ordinary Shares	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Ordinary Shares	'
	ORDINARY SHARES
	Changes in the number of ordinary shares issued during the nine months ended September 30, 2014, and September 30, 2013, are represented in the table below:
		2014	2013
	Ordinary shares issued - beginning balance	71,016,771	55,884,718
	Issuance of new ordinary shares	—	15,132,053
	Ordinary shares issued – ending balance	71,016,771	71,016,771
	On January 22, 2013, the underwriters exercised a portion of their over-allotment option from our December 24, 2012, offering of ordinary shares in the amount of 970,578 ordinary shares. We received net proceeds of $17,633 from the over-allotment exercise.
	On June 26, 2013, we issued 13,000,000 of our ordinary shares, and an additional 1,161,475 of ordinary shares were issued in connection with the exercise of the underwriters' over-allotment option. The total gross proceeds from the issuance of these additional shares to HLSS were $325,714. After deducting underwriting discounts, commissions and expenses payable by HLSS, the aggregate net proceeds we received were $315,918.

Earnings_Per_Share_Earnings_Pe

Earnings Per Share Earnings Per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share	'
	EARNINGS PER SHARE ("EPS")
	Basic EPS is computed by dividing reported net income by weighted average number of ordinary shares outstanding during each period. Diluted EPS is computed by dividing reported net income by the weighted average ordinary shares and all potential dilutive ordinary shares outstanding during the period.
	The following table presents the computation of per share earnings for the three and nine months ended September 30:
			Three months				Nine months
	(In thousands, except per share data)		2014		2013		2014		2013
	Net income		$	49,214	$	39,166	$	164,234	$	111,077
	Weighted average ordinary shares outstanding		71,016,771		71,016,771		71,016,771		61,812,369
	Weighted average potential dilutive ordinary shares		1,771		—		—		—
	Average diluted ordinary shares		71,018,542		71,016,771		71,016,771		61,812,369
	Basic earnings per share		$	0.69	$	0.55	$	2.31	$	1.8
	Diluted earnings per share		$	0.69	$	0.55	$	2.31	$	1.8
	Stock options excluded from the computation of diluted EPS:
	Anti-dilutive (1)		465,000		—		515,000		—
	Market-based (2)		515,000		—		515,000		—
	-1	These stock options were anti-dilutive because their exercise price was greater than the average market price of our stock.
	-2	Shares that are issuable upon the achievement of certain performance criteria related to our stock price and an annualized rate of return to investors. Note 14 provides details of our share-based compensation.

Derivative_Financial_Instrumen

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Financial Instruments	'
	DERIVATIVE FINANCIAL INSTRUMENTS
	We are party to interest rate swap agreements that we recognize on our Interim Condensed Consolidated Balance Sheet at fair value within Other assets and Other liabilities. On the date we entered into the interest rate swap agreements, we designated and documented them as hedges of the variable cash flows payable for floating rate interest expense on our borrowings (cash flow hedge). To qualify for hedge accounting, a derivative must be highly effective at reducing the risk associated with the hedged exposure. In addition, the documentation must include the risk management objective and strategy. On a quarterly basis we assess and document the derivatives’ effectiveness and expected effectiveness in offsetting the changes in the fair value or the cash flows of the hedged items. To assess effectiveness, we use statistical methods, such as regression analysis, as well as nonstatistical methods including dollar-offset analysis. For a cash flow hedge, to the extent that it is effective, we record changes in the estimated fair value of the derivative in accumulated other comprehensive income ("AOCI"). We subsequently reclassify these changes in estimated fair value to net income in the same period that the hedged transaction affects earnings and in the same financial statement category as the hedged item.
	If a derivative instrument in a cash flow hedge is terminated or the hedge designation is removed, we reclassify related amounts in AOCI into earnings in the same period during which the cash flows that were hedged affect earnings. In a period where we determine that it is probable that a hedged forecasted transaction will not occur, such as variable-rate interest payments on debt that has been repaid in advance, any related amounts in AOCI are reclassified into earnings in that period.
	Because our current derivative agreements are not exchange-traded, we are exposed to credit loss in the event of nonperformance by the counterparty to the agreement. We control this risk through counterparty credit monitoring procedures including financial analysis, dollar limits and other monitoring procedures. The notional amounts of our contracts do not represent our exposure to credit loss. See Note 3 for additional information regarding our use of derivatives.
	Interest Rate Management
	We executed a hedging strategy designed to mitigate the impact of changes in variable interest rates on the excess of interest rate sensitive liabilities over interest rate sensitive assets. We entered into interest rate swaps to hedge against the effects of a change in 1-Month LIBOR.
	The following tables provide information about our interest rate swaps at September 30, 2014, and December 31, 2013, respectively:
	Purpose		Date Opened		Effective Date (1)		Maturity		We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges (2) (3):
	Hedge the effects of changes in 1-Month LIBOR		Sep-12		Sep-12		Aug-17		0.5188	%	1-Month LIBOR	Other assets	$	92,121	$	1,767
	Hedge the effects of changes in 1-Month LIBOR		Jan-13		Jan-16		Dec-17		1.3975	%	1-Month LIBOR	Other assets	338,009		1,097
	Hedge the effects of changes in 1-Month LIBOR		May-12		May-12		May-16		0.607	%	1-Month LIBOR	Other assets	19,795		7
	Total asset derivatives designated as hedges as of September 30, 2014												$	449,925	$	2,871
	Total asset derivatives as of September 30, 2014												$	449,925	$	2,871
	Purpose		Date Opened		Effective Date (1)		Maturity		We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges (2) (3):
	Hedge the effects of changes in 1-Month LIBOR		Mar-12		Mar-12		Mar-16		0.6325	%	1-Month LIBOR	Other liabilities	$	86,358	$	(229	)
	Total liability derivatives designated as hedges as of September 30, 2014												$	86,358	$	(229	)
	Total liability derivatives as of September 30, 2014												$	86,358	$	(229	)
	Purpose		Date Opened		Effective Date (1)		Maturity		We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges (3):
	Hedge the effects of changes in 1-Month LIBOR		Sep-12		Sep-12		Aug-17		0.5188	%	1-Month LIBOR	Other assets	$	177,056	$	1,084
	Hedge the effects of changes in 1-Month LIBOR		Jan-13		Jan-16		Dec-17		1.3975	%	1-Month LIBOR	Other assets	338,009		2,751
	Total asset derivatives designated as hedges as of December 31, 2013												$	515,065	$	3,835
	Total asset derivatives as of December 31, 2013												$	515,065	$	3,835
	Purpose		Date Opened		Effective Date (1)		Maturity		We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges (3):
	Hedge the effects of changes in 1-Month LIBOR		Mar-12		Mar-12		Mar-16		0.6325	%	1-Month LIBOR	Other liabilities	$	102,522	$	(364	)
	Hedge the effects of changes in 1-Month LIBOR		May-12		May-12		May-16		0.607	%	1-Month LIBOR	Other liabilities	28,565		(25		)
	Hedge the effects of changes in 1-Month LIBOR		Jan-13		Jan-14		Jul-14		0.3375	%	1-Month LIBOR	Other liabilities	307,043		(140		)
	Total liability derivatives designated as hedges as of December 31, 2013												$	438,130	$	(529	)
	Total liability derivatives as of December 31, 2013												$	438,130	$	(529	)
	-1	The effective date of the swap is the date from which monthly net settlements begin to be computed.
	-2	Projected net settlements for the next twelve months total approximately $633 of payments to the counterparty.
	-3	There was an unrealized pre-tax gain of $1,341 and an unrealized pre-tax loss of $664 related to our interest rate swaps included in AOCI for the three and nine months ended September 30, 2014, respectively. There was an unrealized pre-tax loss of $1,592 and an unrealized pre-tax gain of $3,761 related to our interest rate swaps included in AOCI for the three and nine months ended September 30, 2013, respectively. Given the current and expected effectiveness of our hedging arrangements, we do not expect any reclassifications from AOCI into earnings associated with hedging ineffectiveness related to these hedging arrangements during the next twelve months.
	The following table summarizes our use of derivatives during the nine months ended September 30:
		2014				2013
	Notional balance at beginning of period	$	953,195			$	414,631
	Additions	—				645,052
	Maturities	(71,122		)		—
	Terminations	—				—
	Amortization	(345,790		)		(67,898		)
	Notional balance at end of period	$	536,283			$	991,785
	We recognize the right to reclaim cash collateral or the obligation to return cash collateral as part of our hedge agreements. At September 30, 2014, we have the right to reclaim cash collateral of $1,075 and are obligated to return cash collateral of $2,820 as part of our hedge agreements. At December 31, 2013, we had the right to reclaim cash collateral of $1,075 and were obligated to return cash collateral of $3,500 as part of our hedge agreements.

Interest_Income

Interest Income	9 Months Ended
	Sep. 30, 2014
Other Income and Expenses [Abstract]	'
Interest Income	'
	INTEREST INCOME
	Interest Income – Notes Receivable – Rights to MSRs
	Our primary source of revenue is the fees we are entitled to receive in connection with the servicing of mortgage loans. We account for these fees as interest income.
	The following table shows how we calculated Interest income – notes receivable – Rights to MSRs for the three and nine months ended September 30:
		Three Months						Nine Months
		2014			2013			2014			2013
	Servicing fees collected	$	177,113		$	200,838		$	551,960		$	431,795
	Subservicing fee payable to Ocwen	(83,634		)	(102,040		)	(265,179		)	(214,587		)
	Net servicing fees retained by HLSS	93,479			98,798			286,781			217,208
	Reduction in Notes receivable – Rights to MSRs	(10,617		)	(17,763		)	(14,807		)	(25,102		)
	Servicing transfers (1)	1,988			—			1,988			—
	Increase (decrease) in the fair value of Notes	—			(2,588		)	—			—
	receivable – Rights to MSRs
		$	84,850		$	78,447		$	273,962		$	192,106
	-1	Ocwen is required to reimburse us in the event of a transfer of servicing at predetermined contractual rates.
	Interest Income – Other
	Additional sources of revenue for us are the interest we earn on our GNMA EBO loans, interest we earn on our RPLs, financing of GNMA EBO and other advances and interest we earn on operating bank accounts and the custodial account balances related to the mortgage loans serviced that are not included in our Interim Condensed Consolidated Balance Sheets. The following table shows our Interest income – other for the three and nine months ended September 30:
		Three Months						Nine Months
		2014			2013			2014			2013
	Loan interest (1)	$	9,811		$	—		$	17,365		$	—
	Advance financing interest (2)	989			—			2,143			—
	Bank account interest	1,318			697			3,361			896
		$	12,118		$	697		$	22,869		$	896
	-1	Represents interest earned at the stated note rate on each individual GNMA EBO loan, net of the amortization of the purchase premium on our GNMA EBO and other loans using the interest method of accounting, and the accretion of the accretable yield on our pools of RPLs using the interest method of accounting.
	-2	Represents interest earned on servicing advance financing we provided to Ocwen.

Interest_Expense

Interest Expense	9 Months Ended
	Sep. 30, 2014
Interest Expense [Abstract]	'
Interest Expense	'
	INTEREST EXPENSE
	The following table presents the components of Interest expense for the three and nine months ended September 30:
		Three Months				Nine Months
		2014		2013		2014		2013
	Match funded liabilities	$	28,580	$	27,108	$	82,536	$	57,793
	Other borrowings	9,732		4,214		23,016		4,423
	Amortization of debt issuance costs	5,600		4,426		15,160		11,113
	Interest rate swaps	234		332		946		1,027
		$	44,146	$	36,080	$	121,658	$	74,356

Sharebased_Compensation

Share-based Compensation	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Share-based Compensation	'
	SHARE-BASED COMPENSATION
	On December 5, 2013, the Board of Directors of HLSS adopted the 2013 Equity Incentive Plan (the “Plan”), subject to the approval of the shareholders. At the Annual Meeting of Shareholders on May 13, 2014, the shareholders approved the Plan.
	The Plan is administered by the Compensation Committee, which may authorize the award of options, restricted shares, share appreciation rights, performance awards or other share-based awards to our employees of an amount not exceeding 2,000,000 ordinary shares, in aggregate. Currently, other than share options with vesting terms, the Compensation Committee does not expect to grant any restricted shares, share appreciation rights, performance awards or other share-based awards under the Plan. Each option award under the Plan is, and will be, evidenced by a written award agreement between the participant and HLSS. The award agreement describes the award and states the terms and conditions to which the award is subject.
	Outstanding share-based compensation currently consists of stock option grants that are a combination of service-based and market-based options.
	Service-Based Options. These options are granted at fair value on the date of grant. The options generally vest evenly in four annual increments beginning with the first anniversary of the agreement date, and the options generally expire on the earlier of 10 years after the date of grant or following termination of service. A total of 515,000 service-based awards were outstanding at September 30, 2014.
	Market-Based Options. These options are subject to market-based vesting. One-fourth of the options will vest immediately on the first date as of which both of the following market-based criteria have been met: i) the per share price must be equal to or exceed 1.25 times the strike price and ii) investors must achieve a 12.5% annualized rate of return from the agreement date based on the strike price and dividends received. Thereafter, the remaining options will vest evenly on each of the next three anniversaries of the initial date of vesting. A total of 515,000 market-based awards were outstanding at September 30, 2014.
	Both Service-Based Options and Market-Based Options that are vested and outstanding will be entitled to receive payments equal to the amount of the then current dividend as if the underlying shares were issued at the ex-dividend date. No expense related to this feature was recognized during the period ending September 30, 2014.
	The fair value of the Service-Based Options was determined using the Black-Scholes option pricing model, and a lattice (binomial) model was used to determine the fair value of the Market-Based Options using the following assumptions as of the grant date:
			For the nine months ended September 30, 2014
			Black-Scholes			Binomial
	Risk-free interest rate		2.13	%		0.13% - 3.23%
	Expected stock price volatility		19.62	%		19.62	%
	Expected dividend yield		7.82	%		7.82	%
	Expected option life (in years)		6.5			2.7 - 3.5
	Contractual life (in years)		10			10
	Fair Value		$0.87 - $1.27			$0.53 - $1.43
	Share-based compensation expense is recorded net of an estimated forfeiture rate of 4%.
	A summary of option activity under the Plan for the nine months ended September 30, 2014, is presented below.
		Shares			Weighted Average Exercise Price			Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (1)
	Outstanding at December 31, 2013	—			$	—		0	$	—
	Granted	1,280,000			22.9
	Exercised	—			—
	Forfeited or expired	(250,000	)		23.12
	Outstanding at September 30, 2014	1,030,000			$	22.85		9.2	$	—
	Exercisable at September 30, 2014	—			$	—		0	$	—
	-1	Intrinsic value represents the difference between the Company’s closing stock price and the exercise price multiplied by the number of options outstanding and exercisable at a price below that closing price.
	The weighted-average grant-date fair value of options granted during 2014 is $0.75 per share. As of September 30, 2014, the Company has $0.6 million of total unrecognized compensation expense related to non-vested share option awards granted under the Plan. The total expense is expected to be recognized over the weighted-average requisite service period of 3.1 years. No shares vested during the period ended September 30, 2014.
	No option awards, whether vested or non-vested, were outstanding for the nine months ended September 30, 2013, and no option activity occurred during this period.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	INCOME TAXES
	Income taxes were provided for based upon the tax laws and rates in the countries in which we conduct operations and earn related income. Our effective tax rate for the three and nine months ended September 30, 2014, was 0.0% and 0.0%, respectively (2.2% and 0.9% for the three and nine months ended September 30, 2013, respectively). We are a Cayman Islands exempted company, and the Cayman Islands currently levies no taxes on individuals or corporations based upon profits, income, gains or appreciation.
	The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities. As of September 30, 2014, the Company did not have any unrecognized tax benefits related to the current period or any previous period. We recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. We did not accrue interest or penalties associated with any unrecognized tax benefits, nor was any interest expense or penalty recognized during the period or in previous periods.

Business_Segment_Reporting

Business Segment Reporting	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Business Segment Reporting	'
	BUSINESS SEGMENT REPORTING
	Our business strategy focuses on acquiring mortgage servicing rights and the related servicing advances, Loans held for investment and other residential mortgage-related assets. As of September 30, 2014, we operate a single reportable business segment that holds Residential Mortgage Assets.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	RELATED PARTY TRANSACTIONS
	We entered into various agreements with Ocwen and Altisource Portfolio Solutions, S.A. (“Altisource”) in connection with our Initial Public Offering on March 5, 2012. William C. Erbey, our founder and the Chairman of our Board of Directors, is also the Chairman of the Board of Directors of Ocwen and Altisource.
	As the named servicer, Ocwen remains obligated to perform as servicer under the related pooling and servicing agreements ("PSAs"), and we are required to pay Ocwen a monthly fee for the servicing activities it performs. We are also required to purchase any servicing advances that Ocwen is required to make pursuant to such PSAs.
	Ocwen is also the named servicer on the GNMA EBO loans and RPLs, and we are required to pay Ocwen a monthly fee for the servicing activities it performs.
	On May 1, 2014, we entered into an agreement with Ocwen to finance servicing advances totaling $20,157 and to finance future advances. We account for these receivables as Other assets in the Interim Condensed Consolidated Balance Sheets. We receive interest income on these receivables at a rate of 1-month LIBOR plus 550 bps. We record this interest income as Interest income – other in the Interim Condensed Consolidated Statements of Operations.
	In addition to the acquisition of Residential Mortgage Assets described in Note 2, the following table summarizes our transactions with Ocwen for the three and nine months ended September 30:
		Three Months						Nine Months
		2014			2013			2014			2013
	Servicing fees collected	$	177,113		$	200,838		$	551,960		$	431,795
	Subservicing fee payable to Ocwen	(83,634		)	(102,040		)	(265,179		)	(214,587		)
	Net servicing fees retained by HLSS (1)	93,479			98,798			286,781			217,208
	Servicing advances purchased from Ocwen in the	$	3,958,104		$	3,590,458		$	10,829,858		$	5,111,443
	ordinary course of business
	-1	Net servicing fees retained by HLSS are included in the Interim Condensed Consolidated Statements of Operations as a component of Interest income. See Note 12 for additional information regarding our Interest income.
	At September 30, 2014, as a result of servicing activities related to our Notes receivable – Right to MSRs, Ocwen owed us $5,837 for servicing fees collected but not remitted to us, and we owed Ocwen $5,860 for the subservicing fee earned by Ocwen in September 2014. Ocwen owed us $343 for interest accrued on financing of servicing advances as of September 30, 2014. During the three and nine months ended September 30, 2014, we earned interest income on financing of servicing advances of $989 and $2,143 ($0 during the three and nine months ended September 30, 2013). Lastly, our Notes receivable – Rights to MSRs resulted from transactions with Ocwen.
	Ocwen Professional Services Agreement
	We have a professional services agreement with Ocwen (“Professional Services Agreement”) that requires us to provide certain services to Ocwen and for Ocwen to provide certain services to us. Services provided by us under this agreement include valuation and analysis of mortgage servicing rights, capital markets activities, advance financing management, treasury management, legal services and other similar services. Services provided by Ocwen under this agreement include business strategy, legal, tax, licensing and regulatory compliance support services, risk management services and other similar services. The services provided by the parties under this agreement are on an as-needed basis, and the fees represent actual costs incurred plus an additional markup of 15%.
	At September 30, 2014, Ocwen owed us $827 for professional services provided pursuant to the Professional Services Agreement. During the three and nine months ended September 30, 2014, we earned fees of $320 and $1,721 ($491 and $1,458 during the three and nine months ended September 30, 2013) for services provided to Ocwen pursuant to the Professional Services Agreement. Additionally, during the three and nine months ended September 30, 2014, we incurred fees of $131 and $510 ($30 and $90 during the three and nine months ended September 30, 2013) for services received from Ocwen pursuant to the Professional Services Agreement.
	Altisource Administrative Services Agreement
	We have an administrative services agreement with Altisource (“Altisource Administrative Services Agreement”) that requires Altisource to provide certain administrative services to us. Services provided to us under this agreement include human resources administration (benefit plan design, recruiting, hiring and training and compliance support), legal and regulatory compliance support services, general business consulting, corporate services (facilities management, security and travel services), finance and accounting support services (financial analysis, financial reporting and tax services), risk management services, vendor management and other related services. The services Altisource provides to us under this agreement are on an as-needed basis, and the fees we pay Altisource are based on the actual costs incurred by them plus an additional markup of 15%. During the three and nine months ended September 30, 2014, we incurred fees of $259 and $748 ($178 and $530 during the three and nine months ended September 30, 2013) for services provided to us pursuant to the Altisource Administrative Services Agreement.
	Receivables from and Payables to Related Parties
	The following table summarizes amounts receivable from and payable to related parties at the dates indicated:
		September 30, 2014			December 31, 2013
	Servicing fees collected (1)	$	5,837		$	8,482
	Professional services (2)	827			655
	Advance collections (3)	15,352			60,239
	Receivable from servicing transfers (4)	1,988			—
	Other	2,219			673
	Receivables from Ocwen	$	26,223		$	70,049
	Subservicing fees payable (5)	$	5,860		$	8,114
	Professional services (2)	290			354
	Other	2,134			2,181
	Payables to Ocwen	$	8,284		$	10,649
	Payables to Altisource	$	233		$	83
	-1	Ocwen is required to remit to us servicing fees it collects on our behalf within two business days. The amount due from Ocwen at September 30, 2014, represents servicing fees collected but not remitted at the end of the month. We record servicing fees we collect less the subservicing fee we pay to Ocwen less the reduction in Notes receivable – Rights to MSRs as Interest income as shown in Note 12.
	-2	The respective amounts are for professional services provided that were outstanding as of the dates indicated.
	-3	Upon collection, Ocwen is contractually obligated to remit Match funded advance collections to pay down our Match funded liabilities. This receivable represents the portion of Match funded advance collections that were in-transit to pay down our Match funded liabilities as of the dates indicated.
	-4	Ocwen is required to reimburse us in the event of a transfer of servicing at predetermined contractual rates.
	-5	The base fee and performance fee, if any, that comprise the subservicing fees payable are calculated and paid to Ocwen within three business days following the end of the month.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	COMMITMENTS AND CONTINGENCIES
	We may be party to various claims, legal actions and complaints arising in the ordinary course of business. We monitor our legal matters, including advice from external legal counsel, and periodically perform assessments of these matters for potential loss accrual and disclosure. There are currently no probable matters outstanding that, in the opinion of management, will have a material effect on our Interim Condensed Consolidated Balance Sheets, Statements of Operations and Statements of Cash Flows. There are also currently no reasonably possible matters outstanding that, in the opinion of management, will have a material effect on our Interim Condensed Consolidated Balance Sheets, Statements of Operations and Statements of Cash Flows.
	On September 15, 2014 we received a subpoena from the SEC requesting that we provide certain information related to our prior accounting conventions for and valuations of our Notes receivable - Rights to MSRs that resulted in the restatement described in Part I, Item I, “Interim Condensed Consolidated Financial Statements - Note 20, Restatement”. We are cooperating with the SEC in this matter.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	SUBSEQUENT EVENTS
	Subsequent to our balance sheet date of September 30, 2014:
	•	On October 10, 2014, we paid cash dividends of $12,783 or $0.18 per ordinary share,
	•	On October 16, 2014, we purchased a portfolio of EBO loans from an unrelated third party with a total UPB of $142.5 million, and
	•	On October 16, 2014, we declared a monthly dividend of $0.18 per ordinary share with respect to October, November and December 2014.

Restatement

Restatement	9 Months Ended
	Sep. 30, 2014
Accounting Changes and Error Corrections [Abstract]	'
Restatement	'
	RESTATEMENT
	Subsequent to the filing of our Annual Report on Form 10-K for the fiscal year ended December 31, 2013 with the SEC on February 6, 2014, we determined that the Notes receivable – Rights to MSRs and related interest income were materially misstated due to the fact that we did not adjust the Notes receivable – Rights to MSRs to the best estimate of fair value. As a result, the following financial statement amounts have been restated from amounts previously reported.
	The following table summarizes the effects of the restatement on the consolidated balance sheet as of December 31, 2013 (as restated on the 2013 Form 10-K/A).
		December 31, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Notes Receivable – Rights to MSRs	$	651,060		$	(17,291	)	$	633,769
	All other assets	6,676,903			—			6,676,903
	Total assets	$	7,327,963		$	(17,291	)	$	7,310,672
	Total liabilities	$	6,094,225		$	—		$	6,094,225
	Retained earnings	20,804			(17,291		)	3,513
	All other equity	1,212,934			—			1,212,934
	Total equity	1,233,738			(17,291		)	1,216,447
	Total liabilities and equity	$	7,327,963		$	(17,291	)	$	7,310,672
	The following table summarizes the effects of the restatement on the consolidated statements of operations for the three and nine months ended September 30, 2013.
		Three months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Interest income – notes receivable – Rights to MSRs	$	74,204		$	4,243		$	78,447
	Interest income – other	697			—			697
	Total interest income	74,901			4,243			79,144
	Related party revenue	491			—			491
	Total revenue	75,392			4,243			79,635
	Operating expenses	3,612			—			3,612
	Income from operations	71,780			4,243			76,023
	Other expense
	Interest expense	36,080			—			36,080
	Total other expense	36,080			—			36,080
	Income before income taxes	35,700			4,243			39,943
	Income tax expense	777			—			777
	Net income	$	34,923		$	4,243		$	39,166
	Earnings per share
	Earnings per share	$	0.49		$	0.06		$	0.55
	Diluted earnings per share	$	0.49		$	0.06		$	0.55
		Nine months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Interest income – notes receivable – Rights to MSRs	$	168,626		$	23,480		$	192,106
	Interest income – other	896			—			896
	Total interest income	169,522			23,480			193,002
	Related party revenue	1,458			—			1,458
	Total revenue	170,980			23,480			194,460
	Operating expenses	8,211			—			8,211
	Income from operations	162,769			23,480			186,249
	Other expense
	Interest expense	74,356			—			74,356
	Total other expense	74,356			—			74,356
	Income before income taxes	88,413			23,480			111,893
	Income tax expense	816			—			816
	Net income	$	87,597		$	23,480		$	111,077
	Earnings per share
	Earnings per share	$	1.42		$	0.38		$	1.8
	Diluted earnings per share	$	1.42		$	0.38		$	1.8
	The following table summarizes the effects of the restatement on the consolidated statements of comprehensive income for the three and nine months ended September 30, 2013.
		Three months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Net income	$	34,923		$	4,243		$	39,166
	Total other comprehensive income, net of tax	(988		)	—			(988		)
	Total comprehensive income	$	33,935		$	4,243		$	38,178
		Nine months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Net income	$	87,597		$	23,480		$	111,077
	Total other comprehensive income, net of tax	2,742			—			2,742
	Total comprehensive income	$	90,339		$	23,480		$	113,819
	The following table summarizes the effects of the restatement on the consolidated statement of cash flows for the nine months ended September 30, 2013.
		Nine months ended September 30, 2013
(In thousands)	As Previously Reported			Adjustments			As Restated
Net income	$	87,597		$	23,480		$	111,077
All other operating cash flows	668,568			—			668,568
Net cash provided by operating activities	756,165			23,480			779,645
Reduction in Notes receivable – Rights to MSRs	48,582			(23,480		)	25,102
All other investing cash flows	(3,879,789		)	—			(3,879,789		)
Net cash used in investing activities	(3,831,207		)	(23,480		)	(3,854,687		)
Net cash provided by financing activities	3,075,826			—			3,075,826
Net decrease in cash and cash equivalents	784			—			784
Cash and cash equivalents at beginning of period	76,048			—			76,048
Cash and cash equivalents at end of period	$	76,832		—			$	76,832

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Organization	'
	Organization
	Home Loan Servicing Solutions, Ltd. and its wholly owned subsidiaries (collectively referred to throughout as “HLSS”, “us”, “our”, “we” or the “Company”) focus on acquiring mortgage servicing rights and the related servicing advances, Loans held for investment and other residential mortgage-related assets ("Residential Mortgage Assets").
Basis of Presentation and Use of Estimates	'
	Basis of Presentation and Use of Estimates
	We prepared the accompanying unaudited Interim Condensed Consolidated Financial Statements in conformity with the instructions of the Securities and Exchange Commission (“SEC”) to Form 10-Q for interim financial statements. In our opinion, the accompanying unaudited financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires that we make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates. Material estimates that are particularly significant relate to our fair value measurements of Notes receivable – Rights to MSRs.
Principles of Consolidation	'
	Principles of Consolidation
	Our financial statements include the accounts of Home Loan Servicing Solutions, Ltd. and its wholly owned subsidiaries as well as four variable interest entities (“VIE”) of which we are the primary beneficiary. We eliminate intercompany accounts and transactions in consolidation.
	We evaluate each special purpose entity (“SPE”) for classification as a VIE. When a SPE meets the definition of a VIE and we determine that HLSS is the primary beneficiary, we include the SPE in our Interim Condensed Consolidated Financial Statements.
	Our Match funded advances are in two SPEs along with related Match funded liabilities (the "Match Funded Advances SPEs"). We determined that these SPEs are VIEs of which we are the primary beneficiaries. The accounts of these SPEs are included in our Interim Condensed Consolidated Financial Statements.
	Match funded advances on loans serviced for others result from our transfers of residential loan servicing advances to SPEs in exchange for cash. The SPEs issue debt supported by collections on the transferred advances. We made these transfers under the terms of our advance facility agreements. These transfers do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred advances on our Interim Condensed Consolidated Balance Sheet as Match funded advances and the related liabilities as Match funded liabilities. We use collections on the Match funded advances pledged to the SPEs to repay principal and to pay interest and the expenses of the SPEs. Holders of the debt issued by the SPEs can look only to the assets of the entity itself for satisfaction of the debt and have no recourse against HLSS.
	Our Loans held for investment are in two SPEs along with related Other borrowings (the "Mortgage Loans SPEs"). We determined that these SPEs are VIEs of which we are the primary beneficiaries. The accounts of these SPEs are included in our Interim Condensed Consolidated Financial Statements.
	Loans held for investment are transferred to SPEs in exchange for cash, and the SPEs issue debt collateralized by these loans. These transfers do not qualify for sale accounting because we retain control over the transferred assets. As a result, we account for these transfers as financings and classify the transferred loans on our Interim Condensed Consolidated Balance Sheet as Loans held for investment and the related liabilities as Other borrowings. We use collections on the Loans held for investment pledged to the SPEs to repay principal and to pay interest and the expenses of the SPEs. Holders of the debt issued by the SPEs can look beyond the assets of the SPEs for satisfaction of the debt and therefore have recourse against HLSS. It is our expectation that the cash flows of the SPEs will be sufficient to meet all claims of the debt holders. HLSS is responsible for making any principal or interest payments to the debt holders not covered by the cash flows of the SPEs.
Loans Held for Investment and Related Accrued Income	'
	Loans Held for Investment and Related Accrued Income
	Loans held for investment consist of residential mortgage loans acquired from others. The Company does not originate loans. Each acquired loan is evaluated at acquisition to determine if the loan is impaired at the time of acquisition.
	The Company evaluates purchased loans that are not deemed impaired upon acquisition in accordance with the provisions of Accounting Standards Codification ("ASC") ASC 310-20, Receivables - Nonrefundable Fees and Other Costs. The fair value premium or discount on these loans is amortized into interest income over the weighted average life of the loans using a level yield method. Interest income is accrued at the rate specified in the individual loan agreements based on the unpaid principal balance ("UPB").
	For loans accounted for under ASC 310-20, we periodically evaluate whether all contractual payments will be collected as scheduled according to the contractual terms. We incorporate the probable recovery of such payments resulting from Federal Housing Administration ("FHA") insurance in this analysis, as applicable. We evaluate these loans on a periodic basis to ensure the carrying value is the lower of cost or fair value. We recognized no loan impairments for the three and nine months ended September 30, 2014.
	We periodically evaluate whether our Loans held for investment, including individual loans and pools of loans, should be placed on non-accrual status. All of our Loans held for investment remained on accrual status for the three and nine months ended September 30, 2014.
	The Company evaluates purchased impaired loans in accordance with the provisions of ASC 310-30, Receivables - Loans and Debt Securities Acquired with Deteriorated Credit Quality. Purchased loans are considered impaired if there is evidence of credit deterioration since origination and if it is probable that not all contractually required payments will be collected.
	For impaired loans accounted for under ASC 310-30, we continue to estimate cash flows expected to be collected, adjusted for expected prepayments, on pools of loans sharing common risk characteristics which are treated in the aggregate when applying various valuation techniques. We evaluate at each balance sheet date whether the present value of our pools of loans determined using the effective interest rates has decreased and, if so, recognize a provision for loan loss. For any increases in cash flows expected to be collected, we reduce any loss provisions previously recorded, if applicable, and then adjust the amount of accretable yield recognized on a prospective basis over the pool’s remaining life. We recognized no provisions for loan loss nor any adjustments to the amount of the accretable yield for the three and nine months ended September 30, 2014.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	Accounting Standards Update (“ASU”) 2013-11. This ASU provides explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss or a tax credit exists. Previously, there was diversity in practice, and this ASU is expected to eliminate that diversity in practice. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. Our adoption of this standard effective January 1, 2014, did not have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-04. The objective of this ASU is to reduce diversity by clarifying when an in substance repossession or foreclosure occurs; that is, when a creditor should be considered to have received physical possession of residential real estate property collateralizing a consumer mortgage loan such that the loan receivable should be derecognized and the real estate property recognized. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. We do not expect these amendments to have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-06. This ASU provides technical corrections and improvements to Accounting Standards Codification glossary terms. Our adoption of this standard, effective March 14, 2014, did not have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-14. The amendments in this ASU require that certain government-guaranteed mortgage loans, including those guaranteed by the FHA, be derecognized and that a separate other receivable be recognized upon foreclosure if certain conditions are met. Upon foreclosure on loans that meet these criteria, a separate receivable should be recorded based on the amount of the loan balance expected to be recovered from the guarantor. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2014. We do not expect these amendments to have a material impact on our Interim Condensed Consolidated Financial Statements.
	ASU 2014-15. The amendments in this ASU provide guidance in GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. The amendments in this update are effective for fiscal years and interim periods ending after December 15, 2016. We do not expect these amendments to have a material impact on our Interim Condensed Consolidated Financial Statements.
	Certain disclosures included in the Company’s Annual Report are not required to be included on an interim basis in the Company’s Quarterly Reports on Forms 10-Q. The Company has condensed or omitted these disclosures. Therefore, this Form 10-Q should be read in conjunction with the Company’s amended Annual Report on Form 10-K/A for the year ended December 31, 2013, which was filed with the SEC on August 18, 2014 (the "2013 Form 10-K/A").

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Summary of Assets and Liabilities of SPEs	'
	The following tables summarize the assets and liabilities of our consolidated SPEs at the dates indicated:
	At September 30, 2014		Match Funded Advance SPEs		Mortgage Loans SPEs		Total
	Match funded advances		$	6,100,277	$	—	$	6,100,277
	Loans held for investment		—		832,413		832,413
	Related party receivables (1)		15,352		343		15,695
	Other assets (2)		126,199		108,324		234,523
	Total assets		$	6,241,828	$	941,080	$	7,182,908
	Match funded liabilities		$	5,545,636	$	—	$	5,545,636
	Other borrowings (3)		—		726,565		726,565
	Related party payables		—		134		134
	Other liabilities		4,937		1,900		6,837
	Total liabilities		$	5,550,573	$	728,599	$	6,279,172
	At December 31, 2013		Match Funded Advance SPEs		Mortgage Loans SPEs		Total
	Match funded advances		$	6,387,781	$	—	$	6,387,781
	Loans held for investment		—		—		—
	Related party receivables (1)		60,239		—		60,239
	Other assets (2)		119,902		—		119,902
	Total assets		$	6,567,922	$	—	$	6,567,922
	Match funded liabilities		$	5,715,622	$	—	$	5,715,622
	Other borrowings (3)		—		—		—
	Related party payables		—		—		—
	Other liabilities		4,673		—		4,673
	Total liabilities		$	5,720,295	$	—	$	5,720,295
	-1	Related party receivables principally include Match funded advance collections that were in-transit to pay down our Match funded liabilities as of each presented period. See Note 17 for more information about our Related party receivables.
	-2	Other assets principally include debt service accounts, debt issuance costs and advances we financed as part of asset acquisitions. See Note 6 for more information about our Other assets.
	-3	Other borrowings include the carrying value of our borrowings to acquire Loans held for investment. See Note 8 for more information about our Other borrowings.

Asset_Acquisitions_Tables

Asset Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Summary of Purchase Price of Assets and Liabilities	'
	The following table summarizes the purchase price of the assets we acquired from Ocwen during the nine months ended September 30, 2013 and reconciles the cash used to acquire such assets:
	Notes receivable – Rights to MSRs	$	388,472
	Match funded advances (1)	3,489,907
	Purchase price, as adjusted	3,878,379
	Cash paid to settle previous post-closing adjustments	1,410
	Total cash required	$	3,879,789
	Sources:
	Cash on hand	$	739,597
	Match funded liabilities	3,140,192
	Total cash used	$	3,879,789
	-1	The cash used to purchase these assets is shown within the “Acquisition of advances in connection with the purchase of Residential Mortgage Assets” of the Interim Condensed Consolidated Statement of Cash Flows.
	The following table summarizes the purchase price of assets we acquired during the nine months ended September 30, 2014 and reconciles the cash used to acquire such assets:
	GNMA EBO loans purchase price (1)	$	556,618
	RPL purchase price (1)	276,248
	RPL follow-on purchase (1)	67,647
	Total cash required	$	900,513
	Sources:
	Cash on hand	$	154,743
	Other borrowings	745,770
	Total cash used	$	900,513
	-1	The cash used to purchase these assets is shown within “Purchase of loans held for investment” of the Interim Condensed Consolidated Statement of Cash Flows.

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value and Change in Fair value of Assets and Liabilities on Recurring Basis	'
	The following tables present assets by level within the fair value hierarchy that are measured at fair value on a recurring basis:
	At September 30, 2014:		Fair Value				Level 1				Level 2				Level 3
	Measured at fair value on a recurring basis:
	Assets:
	Notes receivable – Rights to MSRs		$	618,962			$	—			$	—			$	618,962
	Derivative financial instruments		2,871				—				—				2,871
	Total assets		$	621,833			$	—			$	—			$	621,833
	Liabilities:
	Derivative financial instruments		$	229			$	—			$	—			$	229
	Total liabilities		$	229			$	—			$	—			$	229
	At December 31, 2013:		Fair Value				Level 1				Level 2				Level 3
	Measured at fair value on a recurring basis:
	Assets:
	Notes receivable – Rights to MSRs		$	633,769			$	—			$	—			$	633,769
	Derivative financial instruments		3,835				—				—				3,835
	Total assets		$	637,604			$	—			$	—			$	637,604
	Liabilities:
	Derivative financial instruments		$	529			$	—			$	—			$	529
	Total liabilities		$	529			$	—			$	—			$	529
Reconciliation of Changes in Fair Value	'
	The following tables present reconciliations of the fair value and changes in fair value of our Level 3 assets and liabilities that we measure at fair value on a recurring basis:
			2014								2013
	For the three months ended September 30,		Notes receivable – Rights to MSRs				Derivative				Notes receivable – Rights to MSRs				Derivative
							Financial								Financial
							Instruments								Instruments
	Beginning balance		$	629,579			$	1,301			$	440,322			$	4,277
	Purchases and reductions:
	Purchases		—				—				239,850				—
	Reductions		(10,617		)		—				(17,763		)		—
			(10,617		)		—				222,087				—
	Changes in fair value :
	Included in net income (1)		—				—				(2,588		)		—
	Included in other comprehensive income (2)		—				1,341				—				(1,592		)
			—				1,341				(2,588		)		(1,592		)
	Transfers in or out of Level 3		—				—				—				—
	Ending balance		$	618,962			$	2,642			$	659,821			$	2,685
			2014								2013
	For the nine months ended September 30,		Notes receivable – Rights to MSRs				Derivative				Notes receivable – Rights to MSRs				Derivative
							Financial								Financial
							Instruments								Instruments
	Beginning balance		$	633,769			$	3,306			$	296,451			$	(1,076	)
	Purchases and reductions:
	Purchases		—				—				388,472				—
	Reductions		(14,807		)		—				(25,102		)		—
			(14,807		)		—				363,370				—
	Changes in fair value :
	Included in net income (1)		—				—				—				—
	Included in other comprehensive income (2)		—				(664		)		—				3,761
			—				(664		)		—				3,761
	Transfers in or out of Level 3		—				—				—				—
	Ending balance		$	618,962			$	2,642			$	659,821			$	2,685
	-1	At each reporting date, we determine the fair value of our Notes receivable – Rights to MSRs and adjust the carrying value to this amount, and these changes in fair value are included in Interest income in the Interim Condensed Consolidated Statements of Operations. See Note 12 for additional information regarding our Interest income.
	-2	These pre-tax gains (losses) are attributable to derivatives still held at September 30, 2014, and September 30, 2013, respectively.
Effect on Fair Value of Note Receivable - Rights to MSRs	'
	The following table shows the effect on the fair value of the Notes receivable – Rights to MSRs assuming adverse changes to certain key assumptions used in valuing these assets at September 30, 2014, and December 31, 2013:
		Discount Rate				Prepayment Speeds				Delinquency Rates
		100 bps adverse change				10% adverse change				10% adverse change
	At September 30, 2014:
	Notes receivable – Rights to MSRs	$	(11,702	)		$	(22,468	)		$	(65,064	)
		Discount Rate				Prepayment Speeds				Delinquency Rates
		100 bps adverse change				10% adverse change				10% adverse change
	At December 31, 2013:
	Notes receivable – Rights to MSRs	$	(12,988	)		$	(22,537	)		$	(72,560	)
Quantitative Information on Significant Observable Inputs Used for Valuing Note Receivable - Rights to MSRs	'
	The following table provides additional quantitative information on our significant inputs used for valuing our Notes receivable – Rights to MSRs as of September 30, 2014, and December 31, 2013, respectively:
	At September 30, 2014:
	Asset	Unobservable Input		Low			High			Weighted Average
	Notes receivable – Rights to MSRs	Discount Rate		15	%		22	%		19	%
		Prepayment Speeds		12	%		28	%		18	%
		Delinquency Rates		15	%		35	%		25	%
	At December 31, 2013:
	Asset	Unobservable Input		Low			High			Weighted Average
	Notes receivable – Rights to MSRs	Discount Rate		15	%		22	%		20	%
		Prepayment Speeds		12	%		28	%		19	%
		Delinquency Rates		15	%		35	%		25	%
Carrying Values and Fair Value Estimates of Financial Instruments Not Carried at Fair Value	'
	Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value at the dates indicated:
		September 30, 2014				September 30, 2014				December 31, 2013				December 31, 2013
		Carrying Value				Fair Value				Carrying Value				Fair Value
	Financial assets:
	Match funded advances	$	6,100,277			$	6,100,277			$	6,387,781			$	6,387,781
	Loans held for investment	832,413				832,413				—				—
	Total financial assets	$	6,932,690			$	6,932,690			$	6,387,781			$	6,387,781
	Financial liabilities:
	Match funded liabilities	$	5,545,636			$	5,545,596			$	5,715,622			$	5,700,934
	Other borrowings	1,093,837				1,091,443				343,386				346,391
	Total financial liabilities	$	6,639,473			$	6,637,039			$	6,059,008			$	6,047,325

Match_Funded_Advances_Tables

Match Funded Advances (Tables)	9 Months Ended
	Sep. 30, 2014
Transfers and Servicing [Abstract]	'
Match Funded Advances on Residential Loans	'
	Match funded advances on residential loans are comprised of the following at the dates indicated:
		September 30,		December 31,
		2014		2013
	Principal and interest advances	$	2,584,899	$	2,632,092
	Taxes and insurance advances	2,639,700		2,723,390
	Corporate advances	875,678		1,032,299
		$	6,100,277	$	6,387,781

Loans_Held_for_Investment_Tabl

Loans Held for Investment (Tables)	9 Months Ended
	Sep. 30, 2014
Investments, Debt and Equity Securities [Abstract]	'
Schedule of loans held for investment	'
	Our Loans held for investment relate to GNMA EBO loans and RPLs, which are our only classes of Loans held for investment.
		30-Sep-14				31-Dec-13
	GNMA EBO loans	$	490,454			$	—
	RPLs	341,959				—
	Loans held for investment	$	832,413			$	—
Schedule of changes in the carrying amount of accretable yield	'
	Changes in the carrying amount of the accretable yield for RPL pools were as follows for the three and nine months ended September 30, 2014:
			Three months ended September 30, 2014							Nine months ended September 30, 2014
			Accretable Yield				Carrying Amount			Accretable Yield			Carrying Amount
	Beginning balance		$	146,726			$	275,838		$	—		$	—
	Additions		31,658				67,647			178,543			343,895
	Accretable yield adjustments		—				—			—			—
	Accretion		(4,600		)		4,600			(4,759		)	4,759
	Payments and other reductions, net		—				(6,126		)	—			(6,695		)
	Ending balance		$	173,784			$	341,959		$	173,784		$	341,959

Other_Assets_Tables

Other Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]	'
Other Assets	'
	Other assets consisted of the following at the dates indicated:
		September 30,		December 31,
		2014		2013
	Debt service accounts (1)	$	119,716	$	103,910
	Advance financing receivables (2)	84,990		—
	Debt issuance costs (3)	19,539		21,165
	Accrued interest income (4)	14,812		—
	Interest-earning collateral deposits (5)	1,075		1,075
	Derivative financial instruments (6)	2,871		3,835
	Other	283		168
		$	243,286	$	130,153
	-1	Under our advance funding facilities, we are contractually required to remit collections of Match funded advances to the trustee within two days of receipt. We do not use the collected funds to reduce the related Match funded liabilities until the payment dates specified in the indenture. The balance also includes amounts that we set aside to provide for possible shortfalls in the funds available to pay certain expenses and interest. Lastly, this balance includes collections on our Loans held for investment of $7,672, which will be used to pay down a portion of our Other borrowings on the first funding date following quarter end.
	-2	We provided financing to Ocwen for servicing advances. We receive interest income at a rate of 1-Month LIBOR plus a spread ranging from 450 bps to 550 bps.
	-3	Debt issuance costs relate to Match funded liabilities and Other borrowings. We amortize these costs to the earlier of the scheduled amortization date, contractual maturity date or prepayment date of the debt.
	-4	Accrued interest income represents interest earned but not yet collected on our Loans held for investment.
	-5	Interest-earning collateral deposits represent cash collateral held by our counterparty as part of our interest rate swap agreements.
	-6	See Notes 3 and 11 for more information regarding our use of derivatives.

Match_Funded_Liabilities_Table

Match Funded Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Text Block [Abstract]	'
Match Funded Liabilities	'
	Match funded liabilities are comprised of the following at the dates indicated:
								Balance Outstanding
	Borrowing Type (1)		Interest Rate	Maturity	Amortization Date (3)	Unused Borrowing Capacity (4)		September 30, 2014 (5)		December 31, 2013
			-2	-3
	Series 2012 T2 Term Notes		199 – 494 bps	Oct. 2045	Oct. 2015	$	—	$	450,000	$	450,000
	Series 2013 T1 Term Notes		90 – 249 bps	Jan. 2044	Jan. 2014	—		—		650,000
	Series 2013 T1 Term Notes		150 – 323 bps	Jan. 2046	Jan. 2016	—		350,000		350,000
	Series 2013 T1 Term Notes		229 – 446 bps	Jan. 2048	Jan. 2018	—		150,000		150,000
	Series 2013 T2 Term Notes		115 – 239 bps	May-44	May-15	—		375,000		375,000
	Series 2013 T3 Term Notes		179 – 313 bps	May-46	May-17	—		475,000		475,000
	Series 2013 T4 Term Notes		118 – 232 bps	Aug. 2044	Aug. 2014	—		—		200,000
	Series 2013 T5 Term Notes		198 – 331 bps	Aug. 2046	Aug. 2016	—		200,000		200,000
	Series 2013 T6 Term Notes		129 – 223 bps	Sep. 2044	Sep. 2014	—		—		350,000
	Series 2013 T7 Term Notes		198 – 302 bps	Nov. 2046	Nov. 2016	—		300,000		300,000
	Series 2014 T1 Term Notes		124 – 229 bps	Jan. 2045	Jan. 2015	—		600,000		—
	Series 2014 T2 Term Notes		222 – 311 bps	Jan. 2047	Jan. 2017	—		200,000		—
	Series 2014 T3 Term Notes		281 bps	Jun. 2048	Jun. 2018	—		363,000		—
	Series 2012 VF 1 Notes (6)		1-Month LIBOR + 110 – 340 bps	Aug. 2045	Aug. 2015	165,400		534,600		469,050
	Series 2012 VF 2 Notes (6)		1-Month LIBOR + 110 – 340 bps	Aug. 2045	Aug. 2015	165,400		534,600		469,050
	Series 2012 VF 3 Notes (6)		1-Month LIBOR + 110 – 340 bps	Aug. 2045	Aug. 2015	165,400		534,600		469,050
	Series 2013 VF 1 Notes (7)		1-Month LIBOR + 150 - 245 bps	Feb. 2045	Feb. 2015	71,164		478,836		514,972
	Class A Term Money Market Fund Note		1-Month LIBOR + 20 bps	Sep. 2014	Jan. 2014	—		—		265,000
	Class B Term Money Market Fund Note		275 bps	Sep. 2044	Sep. 2014	—		—		28,500
						$	567,364	$	5,545,636	$	5,715,622
	-1	Each term note and variable funding note issuance has four classes, an A, B, C, and D class, with the exception of the Series 2014 T3 Term Notes which have only an A and B class. The Series 2014 T3 Class B Term Notes may be exchanged for notes in three separate classes: BX, CX and DX.
	-2	The weighted average interest rate at September 30, 2014, was 1.80%. We pay interest monthly.
	-3	The amortization date is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the due date for all outstanding balances. After the amortization date, all collections that represent the repayment of Match funded advances pledged to the facilities must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.
	-4	Our unused borrowing capacity is available to us if we have additional eligible collateral to pledge and meet other borrowing conditions. We pay a 0.50% or 0.625% fee on the unused borrowing capacity, which varies by facility.
	-5	On January 17, 2014, we completed the issuance of $600,000 of one-year and $200,000 of three-years term notes. On June 18, 2014, we completed the issuance of $400,000 of four-year term notes, of which we retained $37,000.
	-6	On July 16, 2014, we entered into agreements to extend the amortization dates of our Series 2012 variable funding notes to August 28, 2015.
	-7	On February 14, 2014, the Series 2013 variable funding notes were amended to extend the amortization and maturity dates by one year and to reduce the interest rate spreads compared to December 31, 2013.
Analysis of Borrowing by Expected Maturity	'
	Analysis of Borrowing by Expected Maturity (1):
	Year of Expected Maturity Date	As of September 30, 2014
	2014	$	—
	2015	3,507,636
	2016	850,000
	2017	675,000
	2018 and thereafter	513,000
	Total	$	5,545,636
	-1	The expected maturity date is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.
	Analysis of Other Borrowing by Expected Repayment Date (1):
	Year of Expected Payment Date	As of September 30, 2014
	2014	$	301,130
	2015	455,758
	2016	3,500
	2017	3,500
	2018 and thereafter	334,250
	Total (2)	$	1,098,138
	-1	The EBO Facility, the RPL Facility and the Note Facility expected payment dates are based on the current outstanding balance and maturity date of these facilities.
	-2	The total expected payments include the full face value of the senior secured term loan, which has a current ordinary issuance discount balance of $4,301.

Other_Borrowings_Tables

Other Borrowings (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Other Borrowings	'
	Other borrowings consisted of the following at the dates indicated:
		September 30, 2014		December 31, 2013
	Senior secured term loan facility (1)	$	341,324	$	343,386
	EBO Facility (2)	452,258		—
	RPL Facility (3)	274,306		—
	Note Facility (4)	25,949		—
		$	1,093,837	$	343,386
	-1	On June 27, 2013, we entered into a $350,000 senior secured term loan facility, which was issued at a discount to par. The senior secured term loan facility has a maturity date of June 27, 2020 and an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor. As of September 30, 2014, the interest rate on our senior secured term loan facility was 4.50%.
	-2	On March 3, 2014, we entered into the EBO Facility to finance the purchase of our GNMA EBO loans. The facility has a maturity date of March 2, 2015 and an interest rate of 1-Month LIBOR plus 305 bps.
	-3	On June 26, 2014, we entered into the RPL Facility to finance the purchase of our RPLs. The facility has a maturity date of December 26, 2014 and an interest rate of 1-Month LIBOR plus 250 bps.
	-4	On June 24, 2014, we entered into the Note Facility to partially finance the purchase of $37,000 of notes retained as part of the Series 2014 T3 Term Note issuance on June 18, 2014. The Note Facility matures monthly with a next maturity date of October 23, 2014. The Note Facility has an interest rate of 1-Month LIBOR plus 115 bps.
Analysis of Borrowing by Maturity	'
	Analysis of Borrowing by Expected Maturity (1):
	Year of Expected Maturity Date	As of September 30, 2014
	2014	$	—
	2015	3,507,636
	2016	850,000
	2017	675,000
	2018 and thereafter	513,000
	Total	$	5,545,636
	-1	The expected maturity date is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.
	Analysis of Other Borrowing by Expected Repayment Date (1):
	Year of Expected Payment Date	As of September 30, 2014
	2014	$	301,130
	2015	455,758
	2016	3,500
	2017	3,500
	2018 and thereafter	334,250
	Total (2)	$	1,098,138
	-1	The EBO Facility, the RPL Facility and the Note Facility expected payment dates are based on the current outstanding balance and maturity date of these facilities.
	-2	The total expected payments include the full face value of the senior secured term loan, which has a current ordinary issuance discount balance of $4,301.

Ordinary_Shares_Tables

Ordinary Shares (Tables)	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Increases in Number of Ordinary Shares	'
	in the number of ordinary shares issued during the nine months ended September 30, 2014, and September 30, 2013, are represented in the table below:
		2014	2013
	Ordinary shares issued - beginning balance	71,016,771	55,884,718
	Issuance of new ordinary shares	—	15,132,053
	Ordinary shares issued – ending balance	71,016,771	71,016,771

Earnings_Per_Share_Earnings_Pe1

Earnings Per Share Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Computation of Per Share Earnings	'
	The following table presents the computation of per share earnings for the three and nine months ended September 30:
			Three months				Nine months
	(In thousands, except per share data)		2014		2013		2014		2013
	Net income		$	49,214	$	39,166	$	164,234	$	111,077
	Weighted average ordinary shares outstanding		71,016,771		71,016,771		71,016,771		61,812,369
	Weighted average potential dilutive ordinary shares		1,771		—		—		—
	Average diluted ordinary shares		71,018,542		71,016,771		71,016,771		61,812,369
	Basic earnings per share		$	0.69	$	0.55	$	2.31	$	1.8
	Diluted earnings per share		$	0.69	$	0.55	$	2.31	$	1.8
	Stock options excluded from the computation of diluted EPS:
	Anti-dilutive (1)		465,000		—		515,000		—
	Market-based (2)		515,000		—		515,000		—
	-1	These stock options were anti-dilutive because their exercise price was greater than the average market price of our stock.
	-2	Shares that are issuable upon the achievement of certain performance criteria related to our stock price and an annualized rate of return to investors. Note 14 provides details of our share-based compensation.

Derivative_Financial_Instrumen1

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Interest Rate Swaps	'
	The following tables provide information about our interest rate swaps at September 30, 2014, and December 31, 2013, respectively:
	Purpose		Date Opened		Effective Date (1)		Maturity		We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges (2) (3):
	Hedge the effects of changes in 1-Month LIBOR		Sep-12		Sep-12		Aug-17		0.5188	%	1-Month LIBOR	Other assets	$	92,121	$	1,767
	Hedge the effects of changes in 1-Month LIBOR		Jan-13		Jan-16		Dec-17		1.3975	%	1-Month LIBOR	Other assets	338,009		1,097
	Hedge the effects of changes in 1-Month LIBOR		May-12		May-12		May-16		0.607	%	1-Month LIBOR	Other assets	19,795		7
	Total asset derivatives designated as hedges as of September 30, 2014												$	449,925	$	2,871
	Total asset derivatives as of September 30, 2014												$	449,925	$	2,871
	Purpose		Date Opened		Effective Date (1)		Maturity		We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges (2) (3):
	Hedge the effects of changes in 1-Month LIBOR		Mar-12		Mar-12		Mar-16		0.6325	%	1-Month LIBOR	Other liabilities	$	86,358	$	(229	)
	Total liability derivatives designated as hedges as of September 30, 2014												$	86,358	$	(229	)
	Total liability derivatives as of September 30, 2014												$	86,358	$	(229	)
	Purpose		Date Opened		Effective Date (1)		Maturity		We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges (3):
	Hedge the effects of changes in 1-Month LIBOR		Sep-12		Sep-12		Aug-17		0.5188	%	1-Month LIBOR	Other assets	$	177,056	$	1,084
	Hedge the effects of changes in 1-Month LIBOR		Jan-13		Jan-16		Dec-17		1.3975	%	1-Month LIBOR	Other assets	338,009		2,751
	Total asset derivatives designated as hedges as of December 31, 2013												$	515,065	$	3,835
	Total asset derivatives as of December 31, 2013												$	515,065	$	3,835
	Purpose		Date Opened		Effective Date (1)		Maturity		We Pay		We Receive	Balance Sheet Location	Notional Amount		Fair Value
	Designated as hedges (3):
	Hedge the effects of changes in 1-Month LIBOR		Mar-12		Mar-12		Mar-16		0.6325	%	1-Month LIBOR	Other liabilities	$	102,522	$	(364	)
	Hedge the effects of changes in 1-Month LIBOR		May-12		May-12		May-16		0.607	%	1-Month LIBOR	Other liabilities	28,565		(25		)
	Hedge the effects of changes in 1-Month LIBOR		Jan-13		Jan-14		Jul-14		0.3375	%	1-Month LIBOR	Other liabilities	307,043		(140		)
	Total liability derivatives designated as hedges as of December 31, 2013												$	438,130	$	(529	)
	Total liability derivatives as of December 31, 2013												$	438,130	$	(529	)
	-1	The effective date of the swap is the date from which monthly net settlements begin to be computed.
	-2	Projected net settlements for the next twelve months total approximately $633 of payments to the counterparty.
	-3	There was an unrealized pre-tax gain of $1,341 and an unrealized pre-tax loss of $664 related to our interest rate swaps included in AOCI for the three and nine months ended September 30, 2014, respectively. There was an unrealized pre-tax loss of $1,592 and an unrealized pre-tax gain of $3,761 related to our interest rate swaps included in AOCI for the three and nine months ended September 30, 2013, respectively. Given the current and expected effectiveness of our hedging arrangements, we do not expect any reclassifications from AOCI into earnings associated with hedging ineffectiveness related to these hedging arrangements during the next twelve months.
Summarization of Use of Derivative	'
	The following table summarizes our use of derivatives during the nine months ended September 30:
		2014				2013
	Notional balance at beginning of period	$	953,195			$	414,631
	Additions	—				645,052
	Maturities	(71,122		)		—
	Terminations	—				—
	Amortization	(345,790		)		(67,898		)
	Notional balance at end of period	$	536,283			$	991,785

Interest_Income_Tables

Interest Income (Tables)	9 Months Ended
	Sep. 30, 2014
Notes Receivable - Rights to MSRs	'
Calculation of Interest Income on Notes Receivable	'
	The following table shows how we calculated Interest income – notes receivable – Rights to MSRs for the three and nine months ended September 30:
		Three Months						Nine Months
		2014			2013			2014			2013
	Servicing fees collected	$	177,113		$	200,838		$	551,960		$	431,795
	Subservicing fee payable to Ocwen	(83,634		)	(102,040		)	(265,179		)	(214,587		)
	Net servicing fees retained by HLSS	93,479			98,798			286,781			217,208
	Reduction in Notes receivable – Rights to MSRs	(10,617		)	(17,763		)	(14,807		)	(25,102		)
	Servicing transfers (1)	1,988			—			1,988			—
	Increase (decrease) in the fair value of Notes	—			(2,588		)	—			—
	receivable – Rights to MSRs
		$	84,850		$	78,447		$	273,962		$	192,106
	-1	Ocwen is required to reimburse us in the event of a transfer of servicing at predetermined contractual rates.
Interest Income - other	'
Calculation of Interest Income on Notes Receivable	'
	The following table shows our Interest income – other for the three and nine months ended September 30:
		Three Months						Nine Months
		2014			2013			2014			2013
	Loan interest (1)	$	9,811		$	—		$	17,365		$	—
	Advance financing interest (2)	989			—			2,143			—
	Bank account interest	1,318			697			3,361			896
		$	12,118		$	697		$	22,869		$	896
	-1	Represents interest earned at the stated note rate on each individual GNMA EBO loan, net of the amortization of the purchase premium on our GNMA EBO and other loans using the interest method of accounting, and the accretion of the accretable yield on our pools of RPLs using the interest method of accounting.
	-2	Represents interest earned on servicing advance financing we provided to Ocwen.

Interest_Expense_Tables

Interest Expense (Tables)	9 Months Ended
	Sep. 30, 2014
Interest Expense [Abstract]	'
Components of Interest Expense	'
	The following table presents the components of Interest expense for the three and nine months ended September 30:
		Three Months				Nine Months
		2014		2013		2014		2013
	Match funded liabilities	$	28,580	$	27,108	$	82,536	$	57,793
	Other borrowings	9,732		4,214		23,016		4,423
	Amortization of debt issuance costs	5,600		4,426		15,160		11,113
	Interest rate swaps	234		332		946		1,027
		$	44,146	$	36,080	$	121,658	$	74,356

Sharebased_Compensation_Tables

Share-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of fair value assumptions	'
	The fair value of the Service-Based Options was determined using the Black-Scholes option pricing model, and a lattice (binomial) model was used to determine the fair value of the Market-Based Options using the following assumptions as of the grant date:
			For the nine months ended September 30, 2014
			Black-Scholes			Binomial
	Risk-free interest rate		2.13	%		0.13% - 3.23%
	Expected stock price volatility		19.62	%		19.62	%
	Expected dividend yield		7.82	%		7.82	%
	Expected option life (in years)		6.5			2.7 - 3.5
	Contractual life (in years)		10			10
	Fair Value		$0.87 - $1.27			$0.53 - $1.43
Summary of stock option activity	'
	A summary of option activity under the Plan for the nine months ended September 30, 2014, is presented below.
		Shares			Weighted Average Exercise Price			Weighted Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (1)
	Outstanding at December 31, 2013	—			$	—		0	$	—
	Granted	1,280,000			22.9
	Exercised	—			—
	Forfeited or expired	(250,000	)		23.12
	Outstanding at September 30, 2014	1,030,000			$	22.85		9.2	$	—
	Exercisable at September 30, 2014	—			$	—		0	$	—
	-1	Intrinsic value represents the difference between the Company’s closing stock price and the exercise price multiplied by the number of options outstanding and exercisable at a price below that closing price.

Related_Party_Transactions_Tab

Related Party Transactions (Tables)	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Transactions with Ocwen under Purchase Agreement	'
	In addition to the acquisition of Residential Mortgage Assets described in Note 2, the following table summarizes our transactions with Ocwen for the three and nine months ended September 30:
		Three Months						Nine Months
		2014			2013			2014			2013
	Servicing fees collected	$	177,113		$	200,838		$	551,960		$	431,795
	Subservicing fee payable to Ocwen	(83,634		)	(102,040		)	(265,179		)	(214,587		)
	Net servicing fees retained by HLSS (1)	93,479			98,798			286,781			217,208
	Servicing advances purchased from Ocwen in the	$	3,958,104		$	3,590,458		$	10,829,858		$	5,111,443
	ordinary course of business
Receivable from and Payable to Related Parties	'
	The following table summarizes amounts receivable from and payable to related parties at the dates indicated:
		September 30, 2014			December 31, 2013
	Servicing fees collected (1)	$	5,837		$	8,482
	Professional services (2)	827			655
	Advance collections (3)	15,352			60,239
	Receivable from servicing transfers (4)	1,988			—
	Other	2,219			673
	Receivables from Ocwen	$	26,223		$	70,049
	Subservicing fees payable (5)	$	5,860		$	8,114
	Professional services (2)	290			354
	Other	2,134			2,181
	Payables to Ocwen	$	8,284		$	10,649
	Payables to Altisource	$	233		$	83
	-1	Ocwen is required to remit to us servicing fees it collects on our behalf within two business days. The amount due from Ocwen at September 30, 2014, represents servicing fees collected but not remitted at the end of the month. We record servicing fees we collect less the subservicing fee we pay to Ocwen less the reduction in Notes receivable – Rights to MSRs as Interest income as shown in Note 12.
	-2	The respective amounts are for professional services provided that were outstanding as of the dates indicated.
	-3	Upon collection, Ocwen is contractually obligated to remit Match funded advance collections to pay down our Match funded liabilities. This receivable represents the portion of Match funded advance collections that were in-transit to pay down our Match funded liabilities as of the dates indicated.
	-4	Ocwen is required to reimburse us in the event of a transfer of servicing at predetermined contractual rates.
	-5	The base fee and performance fee, if any, that comprise the subservicing fees payable are calculated and paid to Ocwen within three business days following the end of the month.

Restatement_Tables

Restatement (Tables)	9 Months Ended
	Sep. 30, 2014
Accounting Changes and Error Corrections [Abstract]	'
Schedule of Error Corrections and Prior Period Adjustments	'
	The following table summarizes the effects of the restatement on the consolidated balance sheet as of December 31, 2013 (as restated on the 2013 Form 10-K/A).
		December 31, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Notes Receivable – Rights to MSRs	$	651,060		$	(17,291	)	$	633,769
	All other assets	6,676,903			—			6,676,903
	Total assets	$	7,327,963		$	(17,291	)	$	7,310,672
	Total liabilities	$	6,094,225		$	—		$	6,094,225
	Retained earnings	20,804			(17,291		)	3,513
	All other equity	1,212,934			—			1,212,934
	Total equity	1,233,738			(17,291		)	1,216,447
	Total liabilities and equity	$	7,327,963		$	(17,291	)	$	7,310,672
	The following table summarizes the effects of the restatement on the consolidated statements of operations for the three and nine months ended September 30, 2013.
		Three months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Interest income – notes receivable – Rights to MSRs	$	74,204		$	4,243		$	78,447
	Interest income – other	697			—			697
	Total interest income	74,901			4,243			79,144
	Related party revenue	491			—			491
	Total revenue	75,392			4,243			79,635
	Operating expenses	3,612			—			3,612
	Income from operations	71,780			4,243			76,023
	Other expense
	Interest expense	36,080			—			36,080
	Total other expense	36,080			—			36,080
	Income before income taxes	35,700			4,243			39,943
	Income tax expense	777			—			777
	Net income	$	34,923		$	4,243		$	39,166
	Earnings per share
	Earnings per share	$	0.49		$	0.06		$	0.55
	Diluted earnings per share	$	0.49		$	0.06		$	0.55
		Nine months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Interest income – notes receivable – Rights to MSRs	$	168,626		$	23,480		$	192,106
	Interest income – other	896			—			896
	Total interest income	169,522			23,480			193,002
	Related party revenue	1,458			—			1,458
	Total revenue	170,980			23,480			194,460
	Operating expenses	8,211			—			8,211
	Income from operations	162,769			23,480			186,249
	Other expense
	Interest expense	74,356			—			74,356
	Total other expense	74,356			—			74,356
	Income before income taxes	88,413			23,480			111,893
	Income tax expense	816			—			816
	Net income	$	87,597		$	23,480		$	111,077
	Earnings per share
	Earnings per share	$	1.42		$	0.38		$	1.8
	Diluted earnings per share	$	1.42		$	0.38		$	1.8
	The following table summarizes the effects of the restatement on the consolidated statements of comprehensive income for the three and nine months ended September 30, 2013.
		Three months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Net income	$	34,923		$	4,243		$	39,166
	Total other comprehensive income, net of tax	(988		)	—			(988		)
	Total comprehensive income	$	33,935		$	4,243		$	38,178
		Nine months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Net income	$	87,597		$	23,480		$	111,077
	Total other comprehensive income, net of tax	2,742			—			2,742
	Total comprehensive income	$	90,339		$	23,480		$	113,819
	The following table summarizes the effects of the restatement on the consolidated statement of cash flows for the nine months ended September 30, 2013.
		Nine months ended September 30, 2013
	(In thousands)	As Previously Reported			Adjustments			As Restated
	Net income	$	87,597		$	23,480		$	111,077
All other operating cash flows	668,568			—			668,568
Net cash provided by operating activities	756,165			23,480			779,645
Reduction in Notes receivable – Rights to MSRs	48,582			(23,480		)	25,102
All other investing cash flows	(3,879,789		)	—			(3,879,789		)
Net cash used in investing activities	(3,831,207		)	(23,480		)	(3,854,687		)
Net cash provided by financing activities	3,075,826			—			3,075,826
Net decrease in cash and cash equivalents	784			—			784
Cash and cash equivalents at beginning of period	76,048			—			76,048
Cash and cash equivalents at end of period	$	76,832		—			$	76,832

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
	special_purpose_entity	special_purpose_entity
	Entity	Entity
Accounting Policies [Abstract]	'	'
Loan impairment	$0	$0
Number of variable interest entities which company is the primary beneficiary	4	4
Number of Match Funded Advances SPEs	2	2
Number of Mortgage Loans SPEs	2	2
Allowance for loan loss	$0	$0

Summary_of_Assets_and_Liabilit

Summary of Assets and Liabilities of SPEs (Detail) (USD $)	Sep. 30, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Financial Assets and Liabilities [Line Items]	'		'
Match funded advances	$6,100,277		$6,387,781
Loans held for investment	832,413		0
Related party receivables	26,223		70,049
Other assets	243,286		130,153
Total assets	7,952,345		7,310,672
Match funded liabilities	5,545,636		5,715,622
Other borrowings	1,093,837		343,386
Related party payables	8,517		10,732
Other liabilities	12,685		11,884
Total liabilities	6,675,073		6,094,225
Variable Interest Entity	'		'
Financial Assets and Liabilities [Line Items]	'		'
Match funded advances	6,100,277		6,387,781
Loans held for investment	832,413		0
Related party receivables	15,695	[1]	60,239	[1]
Other assets	234,523	[2]	119,902	[2]
Total assets	7,182,908		6,567,922
Match funded liabilities	5,545,636	[3],[4]	5,715,622	[3]
Other borrowings	726,565	[5]	0	[5]
Related party payables	134		0
Other liabilities	6,837		4,673
Total liabilities	6,279,172		5,720,295
Match Funded Advance SPEs | Variable Interest Entity	'		'
Financial Assets and Liabilities [Line Items]	'		'
Match funded advances	6,100,277		6,387,781
Loans held for investment	0		0
Related party receivables	15,352	[1]	60,239	[1]
Other assets	126,199	[2]	119,902	[2]
Total assets	6,241,828		6,567,922
Match funded liabilities	5,545,636		5,715,622
Other borrowings	0	[5]	0	[5]
Related party payables	0		0
Other liabilities	4,937		4,673
Total liabilities	5,550,573		5,720,295
Mortgage Loans SPEs | Variable Interest Entity	'		'
Financial Assets and Liabilities [Line Items]	'		'
Match funded advances	0		0
Loans held for investment	832,413		0
Related party receivables	343	[1]	0	[1]
Other assets	108,324	[2]	0	[2]
Total assets	941,080		0
Match funded liabilities	0		0
Other borrowings	726,565	[5]	0	[5]
Related party payables	134		0
Other liabilities	1,900		0
Total liabilities	$728,599		$0
[1]	Related party receivables principally include Match funded advance collections that were in-transit to pay down our Match funded liabilities as of each presented period. See Note 17 for more information about our Related party receivables.
[2]	Other assets principally include debt service accounts, debt issuance costs and advances we financed as part of asset acquisitions. See Note 6 for more information about our Other assets.
[3]	Each term note and variable funding note issuance has four classes, an A, B, C, and D class, with the exception of the Series 2014 T3 Term Notes which have only an A and B class. The Series 2014 T3 Class B Term Notes may be exchanged for notes in three separate classes: BX, CX and DX.
[4]	On January 17, 2014, we completed the issuance of $600,000 of one-year and $200,000 of three-years term notes. On June 18, 2014, we completed the issuance of $400,000 of four-year term notes, of which we retained $37,000.
[5]	Other borrowings include the carrying value of our borrowings to acquire Loans held for investment. See Note 8 for more information about our Other borrowings.

Asset_Acquisitions_Additional_

Asset Acquisitions - Additional Information (Detail) (USD $)	Sep. 30, 2013	Mar. 03, 2014	Sep. 30, 2014	Jul. 31, 2014		Jun. 27, 2014		Mar. 03, 2014
In Thousands, unless otherwise specified	Purchase Agreement	Purchase Agreement	Purchase Agreement	Ocwen		Ocwen		Ocwen
	Mortgage Loans One	Mortgage Loans Two	Purchase Four
Business Acquisition [Line Items]	'	'	'	'		'		'
Date of additional asset purchase supplement	'	'	3-Mar-14	'		'		'
Unpaid principal balance of GNMA loans	$109,800,000	$549,411	'	'		'		'
GNMA EBO loans purchase price	'	'	'	'		'		556,618	[1]
Unpaid principal balance of RPL Transaction	'	'	'	92,908		396,939		'
Discount rate for RPL unpaid principal balance	'	'	'	'		30.00%		'
RPL purchase price	'	'	'	$67,647	[1]	$276,248	[1]	$276,248	[1]
[1]	The cash used to purchase these assets is shown within “Purchase of loans held for investment” of the Interim Condensed Consolidated Statement of Cash Flows.

Asset_Acquisitions_Summary_of_

Asset Acquisitions - Summary of Purchase Price of Assets and Liabilities (Detail) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2013

Jul. 31, 2014

Jun. 27, 2014

Mar. 03, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

In Thousands, unless otherwise specified

Ocwen

Ocwen

Ocwen

Ocwen

Ocwen

Ocwen

Ocwen

Ocwen

Ocwen

Mortgage Servicing Rights

Advances To Suppliers

Advances To Suppliers

Sources Of Supply

Sources Of Supply

Business Acquisition [Line Items]

'

'

'

'

'

'

'

'

'

'

'

GNMA EBO loans purchase price

'

'

'

'

'

$556,618

[1]

'

'

'

'

'

RPL purchase price

'

'

'

67,647

[1]

276,248

[1]

276,248

[1]

'

'

'

'

'

Total purchase price

'

'

'

'

'

'

'

900,513

3,879,789

'

'

Cash on hand

'

'

'

'

'

'

'

'

'

154,743

739,597

Notes receivable - Rights to MSRs

'

'

388,472

'

'

'

'

'

'

'

'

Match funded advances

'

'

'

'

'

'

3,489,907

[2]

'

'

'

'

Purchase price

'

'

3,878,379

'

'

'

'

'

'

'

'

Post-closing adjustments

'

'

1,410

'

'

'

'

'

'

'

'

Match funded liabilities

'

'

'

'

'

'

'

'

'

'

3,140,192

Other borrowings

$1,093,837

$343,386

'

'

'

'

'

'

'

$745,770

'

[1]

The cash used to purchase these assets is shown within “Purchase of loans held for investment” of the Interim Condensed Consolidated Statement of Cash Flows.

[2]

The cash used to purchase these assets is shown within the “Acquisition of advances in connection with the purchase of Residential Mortgage Assets” of the Interim Condensed Consolidated Statement of Cash Flows.

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2014
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]	'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR plus 3.50%
LIBOR	'
Fair Value, Concentration of Risk, Financial Statement Captions [Line Items]	'
Percentage added for interest rate	3.50%

Fair_Value_of_Financial_Instru3

Fair Value of Financial Instruments - Fair Value and Changes in Assets and Liabilities Measured on Recurring Basis (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Financial assets:	'	'
Derivative financial instruments	$2,871	$3,835	[1]
Recurring, Fair Value	'	'
Financial assets:	'	'
Notes receivable - Rights to MSRs	618,962	633,769
Derivative financial instruments	2,871	3,835
Total financial assets	621,833	637,604
Financial liabilities:	'	'
Derivative financial instruments	229	529
Total financial liabilities	229	529
Recurring, Fair Value | Level 3	'	'
Financial assets:	'	'
Notes receivable - Rights to MSRs	618,962	633,769
Derivative financial instruments	2,871	3,835	[2]
Total financial assets	621,833	637,604
Financial liabilities:	'	'
Derivative financial instruments	229	529
Total financial liabilities	$229	$529
[1]	See Notes 3 and 11 for more information regarding our use of derivatives.
[2]	Interest-earning collateral deposits represent cash collateral held by our counterparty as part of our interest rate swap agreements.

Fair_Value_of_Financial_Instru4

Fair Value of Financial Instruments - Reconciliation of Changes in Fair Value (Detail) (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Notes Receivable - Rights to MSRs	'		'		'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'		'
Beginning balance	$629,579		$440,322		$633,769		$296,451
Purchases and reductions:	'		'		'		'
Purchases	0		239,850		0		388,472
Reductions	-10,617		-17,763		-14,807		-25,102
Total	-10,617		222,087		-14,807		363,370
Changes in fair value :	'		'		'		'
Included in net income	0		-2,588	[1]	0		0
Total	0		-2,588		0		0
Transfers in or out of Level 3	0		0		0		0
Ending balance	618,962		659,821		618,962		659,821
Derivative Financial Instruments	'		'		'		'
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'		'		'		'
Beginning balance	1,301		4,277		3,306		-1,076
Changes in fair value :	'		'		'		'
Included in other comprehensive income	1,341	[2]	-1,592	[2]	-664	[2]	3,761	[2]
Total	1,341		-1,592		-664		3,761
Transfers in or out of Level 3	0		0		0		0
Ending balance	$2,642		$2,685		$2,642		$2,685
[1]	At each reporting date, we determine the fair value of our Notes receivable – Rights to MSRs and adjust the carrying value to this amount, and these changes in fair value are included in Interest income in the Interim Condensed Consolidated Statements of Operations. See Note 12 for additional information regarding our Interest income.
[2]	These pre-tax gains (losses) are attributable to derivatives still held at September 30, 2014, and September 30, 2013, respectively.

Fair_Value_of_Financial_Instru5

Fair Value of Financial Instruments - Effect on Fair Value of Note Receivable - Rights to MSRs (Detail) (Notes Receivable - Rights to MSRs, USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Notes Receivable - Rights to MSRs	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Discount Rate 100 bps adverse change	($11,702)	($12,988)
Prepayment Speeds 10% adverse change	-22,468	-22,537
Delinquency Rates 10% adverse change	($65,064)	($72,560)

Fair_Value_of_Financial_Instru6

Fair Value of Financial Instruments - Quantitative Information on Significant Observable Inputs Used for Valuing Note Receivable - Rights to MSRs (Detail) (Notes Receivable - Rights to MSRs)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Weighted Average - Discount Rate	19.00%	20.00%
Weighted Average - Prepayment Speeds	18.00%	19.00%
Weighted Average - Delinquency Rates	25.00%	25.00%
Low	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Discount Rate	15.00%	15.00%
Prepayment Speeds	12.00%	12.00%
Delinquency Rates	15.00%	15.00%
High	'	'
Fair Value Inputs, Assets, Quantitative Information [Line Items]	'	'
Discount Rate	22.00%	22.00%
Prepayment Speeds	28.00%	28.00%
Delinquency Rates	35.00%	35.00%

Fair_Value_of_Financial_Instru7

Fair Value of Financial Instruments - Carrying Values and Fair Value Estimates of Financial Instruments Not Carried at Fair Value (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Financial assets:	'	'
Match funded advances	$6,100,277	$6,387,781
Loans held for investment	832,413	0
Financial liabilities:	'	'
Match funded liabilities	5,545,636	5,715,622
Other borrowings	1,093,837	343,386
Carrying Value	'	'
Financial assets:	'	'
Match funded advances	6,100,277	6,387,781
Loans held for investment	832,413	0
Total financial assets	6,932,690	6,387,781
Financial liabilities:	'	'
Match funded liabilities	5,545,636	5,715,622
Other borrowings	1,093,837	343,386
Total financial liabilities	6,639,473	6,059,008
Fair Value	'	'
Financial assets:	'	'
Match funded advances	6,100,277	6,387,781
Loans held for investment	832,413	0
Total financial assets	6,932,690	6,387,781
Financial liabilities:	'	'
Match funded liabilities	5,545,596	5,700,934
Other borrowings	1,091,443	346,391
Total financial liabilities	$6,637,039	$6,047,325

Match_Funded_Advances_Resident

Match Funded Advances - Residential Loans (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]	'	'
Match funded advances	$6,100,277	$6,387,781
Variable Interest Entity	'	'
Assets and Associated Liabilities of Transfers Accounted for as Secured Borrowings [Line Items]	'	'
Principal and interest advances	2,584,899	2,632,092
Taxes and insurance advances	2,639,700	2,723,390
Corporate advances	875,678	1,032,299
Match funded advances	$6,100,277	$6,387,781

Loans_Held_for_Investment_Addi

Loans Held for Investment - Additional Information (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Jul. 31, 2014	Jun. 27, 2014	Dec. 31, 2013
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'	'	'
Loans held for investment	$832,413,000	$832,413,000	'	'	$0
Provision for loan loss	0	0	'	'	'
Outstanding balance of RPLs	443,300,000	443,300,000	'	'	'
Contractually required payments receivable	'	'	144,800,000	622,100,000	'
Cash flows expected to be collected	'	'	99,500,000	423,100,000	'
Fair value of RPLs	'	'	67,600,000	276,200,000	'
GNMA EBO Loans	'	'	'	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'	'	'
Loans held for investment	490,454,000	490,454,000	'	'	0
Provision for loan loss	'	0	'	'	'
RPLs	'	'	'	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'	'	'
Loans held for investment	$341,959,000	$341,959,000	'	'	$0

Loans_Held_for_Investment_Chan

Loans Held for Investment - Changes in Carrying Amount of Accretable Yield (Details) (USD $)	3 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Accretable Yield Movement Schedule [Roll Forward]	'	'
Beginning balance	$146,726	$0
Additions	31,658	178,543
Accretable yield adjustments	0	0
Accretion	-4,600	-4,759
Payments and other reductions, net	0	0
Ending balance	173,784	173,784
Certain Loans Acquired in Transfer Not Accounted for as Debt Securities, Carrying Amount Movement Schedule [Roll Forward]	'	'
Beginning balance	275,838	0
Additions	67,647	343,895
Accretable yield adjustments	0	0
Accretion	4,600	4,759
Payments and other reductions, net	-6,126	-6,695
Ending balance	$341,959	$341,959

Other_Assets_Detail

Other Assets (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'
Debt service accounts	$119,716	$103,910	[1]
Advance financing receivable	84,990	0	[2]
Debt issuance costs	19,539	21,165	[3]
Accrued interest income	14,812	0	[4]
Interest-earning collateral deposits	1,075	1,075	[5]
Derivative financial instruments	2,871	3,835	[6]
Other	283	168
Total	243,286	130,153
Period to remit collections on pledged advances to the trustee	'2 days	'
Collections of loans held for investment	$7,672	'
LIBOR	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'
Financing receivable, variable rate	'1-Month LIBOR	'
Minimum | LIBOR	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'
Basis points added to 1-Month LIBOR	4.50%	'
Maximum | LIBOR	'	'
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'
Basis points added to 1-Month LIBOR	5.50%	'
[1]	Under our advance funding facilities, we are contractually required to remit collections of Match funded advances to the trustee within two days of receipt. We do not use the collected funds to reduce the related Match funded liabilities until the payment dates specified in the indenture. The balance also includes amounts that we set aside to provide for possible shortfalls in the funds available to pay certain expenses and interest. Lastly, this balance includes collections on our Loans held for investment of $7,672, which will be used to pay down a portion of our Other borrowings on the first funding date following quarter end.
[2]	We provided financing to Ocwen for servicing advances. We receive interest income at a rate of 1-Month LIBOR plus a spread ranging from 450 bps to 550 bps.
[3]	Debt issuance costs relate to Match funded liabilities and Other borrowings. We amortize these costs to the earlier of the scheduled amortization date, contractual maturity date or prepayment date of the debt.
[4]	Accrued interest income represents interest earned but not yet collected on our Loans held for investment.
[5]	Interest-earning collateral deposits represent cash collateral held by our counterparty as part of our interest rate swap agreements.
[6]	See Notes 3 and 11 for more information regarding our use of derivatives.

Match_Funded_Liabilities_Detai

Match Funded Liabilities (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Debt Instrument [Line Items]	'		'
Ending Balance	$5,545,636		$5,715,622
LIBOR	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	3.50%		'
Variable Interest Entity	'		'
Debt Instrument [Line Items]	'		'
Unused borrowing capacity	567,364	[1],[2]	'
Ending Balance	5,545,636	[1],[3]	5,715,622	[1]
Variable Interest Entity | Series 2012 T2 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'199 – 494 bps	[1],[4]	'
Debt instrument, maturity date	1-Oct-45	[1],[5]	'
Debt instrument, amortization date	'2015-10	[1],[5]	'
Ending Balance	450,000	[1],[3]	450,000	[1]
Variable Interest Entity | Series 2012 T2 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.99%		'
Variable Interest Entity | Series 2012 T2 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	4.94%		'
Variable Interest Entity | Series 2013 T1 Term Notes | Group 1	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'90 – 249 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-44	[1],[5]	'
Debt instrument, amortization date	'2014-01	[1],[5]	'
Ending Balance	0	[1],[3]	650,000	[1]
Variable Interest Entity | Series 2013 T1 Term Notes | Group 1 | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	0.90%		'
Variable Interest Entity | Series 2013 T1 Term Notes | Group 1 | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.49%		'
Variable Interest Entity | Series 2013 T1 Term Notes | Group 2	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'150 – 323 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-46	[1],[5]	'
Debt instrument, amortization date	'2016-01	[1],[5]	'
Ending Balance	350,000	[1],[3]	350,000	[1]
Variable Interest Entity | Series 2013 T1 Term Notes | Group 2 | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.50%		'
Variable Interest Entity | Series 2013 T1 Term Notes | Group 2 | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.23%		'
Variable Interest Entity | Series 2013 T1 Term Notes | Group 3	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'229 – 446 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-48	[1],[5]	'
Debt instrument, amortization date	'2018-01	[1],[5]	'
Ending Balance	150,000	[1],[3]	150,000	[1]
Variable Interest Entity | Series 2013 T1 Term Notes | Group 3 | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.29%		'
Variable Interest Entity | Series 2013 T1 Term Notes | Group 3 | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	4.46%		'
Variable Interest Entity | Series 2013 T2 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'115 – 239 bps	[1],[4]	'
Debt instrument, maturity date	1-May-44	[1],[5]	'
Debt instrument, amortization date	'2015-05	[1],[5]	'
Ending Balance	375,000	[1],[3]	375,000	[1]
Variable Interest Entity | Series 2013 T2 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.15%		'
Variable Interest Entity | Series 2013 T2 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.39%		'
Variable Interest Entity | Series 2013 T3 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'179 – 313 bps	[1],[4]	'
Debt instrument, maturity date	1-May-46	[1],[5]	'
Debt instrument, amortization date	'2017-05	[1],[5]	'
Ending Balance	475,000	[1],[3]	475,000	[1]
Variable Interest Entity | Series 2013 T3 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.79%		'
Variable Interest Entity | Series 2013 T3 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.13%		'
Variable Interest Entity | Series 2013 T4 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'118 – 232 bps	[1],[4]	'
Debt instrument, maturity date	1-Aug-44	[1],[5]	'
Debt instrument, amortization date	'2014-08	[1],[5]	'
Ending Balance	0	[1],[3]	200,000	[1]
Variable Interest Entity | Series 2013 T4 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.18%		'
Variable Interest Entity | Series 2013 T4 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.32%		'
Variable Interest Entity | Series 2013 T5 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'198 – 331 bps	[1],[4]	'
Debt instrument, maturity date	1-Aug-46	[1],[5]	'
Debt instrument, amortization date	'2016-08	[1],[5]	'
Ending Balance	200,000	[1],[3]	200,000	[1]
Variable Interest Entity | Series 2013 T5 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.98%		'
Variable Interest Entity | Series 2013 T5 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.31%		'
Variable Interest Entity | Series 2013 T6 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'129 – 223 bps	[1],[4]	'
Debt instrument, maturity date	1-Sep-44	[1],[5]	'
Debt instrument, amortization date	'2014-09	[1],[5]	'
Ending Balance	0	[1],[3]	350,000	[1]
Variable Interest Entity | Series 2013 T6 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.29%		'
Variable Interest Entity | Series 2013 T6 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.23%		'
Variable Interest Entity | Series 2013 T7 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'198 – 302 bps	[1],[4]	'
Debt instrument, maturity date	1-Nov-46	[1],[5]	'
Debt instrument, amortization date	'2016-11	[1],[5]	'
Ending Balance	300,000	[1],[3]	300,000	[1]
Variable Interest Entity | Series 2013 T7 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.98%		'
Variable Interest Entity | Series 2013 T7 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.02%		'
Variable Interest Entity | Series 2014 T1 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'124 – 229 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-45	[1],[5]	'
Debt instrument, amortization date	'2015-01	[1],[5]	'
Ending Balance	600,000	[1],[3]	0	[1]
Variable Interest Entity | Series 2014 T1 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	1.24%		'
Variable Interest Entity | Series 2014 T1 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.29%		'
Variable Interest Entity | Series 2014 T2 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'222 – 311 bps	[1],[4]	'
Debt instrument, maturity date	1-Jan-47	[1],[5]	'
Debt instrument, amortization date	'2017-01	[1],[5]	'
Ending Balance	200,000	[1],[3]	0	[1]
Variable Interest Entity | Series 2014 T2 Term Notes | Minimum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.22%		'
Variable Interest Entity | Series 2014 T2 Term Notes | Maximum	'		'
Debt Instrument [Line Items]	'		'
Interest rate	3.11%		'
Variable Interest Entity | Series 2014 T3 Term Notes	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.81%		'
Interest rate to calculate the cost of servicing advances	'281 bps	[1],[4]	'
Debt instrument, maturity date	1-Jun-48	[1],[5]	'
Debt instrument, amortization date	'2018-06	[1],[5]	'
Ending Balance	363,000	[1],[3]	0	[1]
Variable Interest Entity | Series 2012 VF 1 Notes | LIBOR	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 110 – 340 bps	[1],[4],[6]	'
Debt instrument, maturity date	1-Aug-45	[1],[5],[6]	'
Debt instrument, amortization date	'2015-08	[1],[5],[6]	'
Unused borrowing capacity	165,400	[1],[2],[6]	'
Ending Balance	534,600	[1],[3],[6]	469,050	[1],[6]
Variable Interest Entity | Series 2012 VF 1 Notes | LIBOR | Minimum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.10%		'
Variable Interest Entity | Series 2012 VF 1 Notes | LIBOR | Maximum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	3.40%		'
Variable Interest Entity | Series 2012 VF 2 Notes | LIBOR	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 110 – 340 bps	[1],[4],[6]	'
Debt instrument, maturity date	1-Aug-45	[1],[5],[6]	'
Debt instrument, amortization date	'2015-08	[1],[5],[6]	'
Unused borrowing capacity	165,400	[1],[2],[6]	'
Ending Balance	534,600	[1],[3],[6]	469,050	[1],[6]
Variable Interest Entity | Series 2012 VF 2 Notes | LIBOR | Minimum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.10%		'
Variable Interest Entity | Series 2012 VF 2 Notes | LIBOR | Maximum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	3.40%		'
Variable Interest Entity | Series 2013 VF 3 Notes | LIBOR	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 110 – 340 bps	[1],[4],[6]	'
Debt instrument, maturity date	1-Aug-45	[1],[5],[6]	'
Debt instrument, amortization date	'2015-08	[1],[5],[6]	'
Unused borrowing capacity	165,400	[1],[2],[6]	'
Ending Balance	534,600	[1],[3],[6]	469,050	[1],[6]
Variable Interest Entity | Series 2013 VF 3 Notes | LIBOR | Minimum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.10%		'
Variable Interest Entity | Series 2013 VF 3 Notes | LIBOR | Maximum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	3.40%		'
Variable Interest Entity | Series 2013 VF 1 Notes | LIBOR	'		'
Debt Instrument [Line Items]	'		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 150 - 245 bps	[1],[4],[7]	'
Debt instrument, maturity date	1-Feb-45	[1],[5],[7]	'
Debt instrument, amortization date	'2015-02	[1],[5],[7]	'
Unused borrowing capacity	71,164	[1],[2],[7]	'
Ending Balance	478,836	[1],[3],[7]	514,972	[1],[7]
Variable Interest Entity | Series 2013 VF 1 Notes | LIBOR | Minimum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	1.50%		'
Variable Interest Entity | Series 2013 VF 1 Notes | LIBOR | Maximum	'		'
Debt Instrument [Line Items]	'		'
Percentage added for interest rate	2.45%		'
Variable Interest Entity | Class A Term Money Market Fund Note | LIBOR	'		'
Debt Instrument [Line Items]	'		'
Interest rate	0.20%		'
Interest rate to calculate the cost of servicing advances	'1-Month LIBOR + 20 bps	[1],[4]	'
Debt instrument, maturity date	1-Sep-14	[1],[5]	'
Debt instrument, amortization date	'2014-01	[1],[5]	'
Ending Balance	0	[1],[3]	265,000	[1]
Variable Interest Entity | Class B Term Money Market Fund Note	'		'
Debt Instrument [Line Items]	'		'
Interest rate	2.75%		'
Interest rate to calculate the cost of servicing advances	'275 bps	[1],[4]	'
Debt instrument, maturity date	1-Sep-44	[1],[5]	'
Debt instrument, amortization date	'2014-09	[1],[5]	'
Ending Balance	$0	[1],[3]	$28,500	[1]
[1]	Each term note and variable funding note issuance has four classes, an A, B, C, and D class, with the exception of the Series 2014 T3 Term Notes which have only an A and B class. The Series 2014 T3 Class B Term Notes may be exchanged for notes in three separate classes: BX, CX and DX.
[2]	Our unused borrowing capacity is available to us if we have additional eligible collateral to pledge and meet other borrowing conditions. We pay a 0.50% or 0.625% fee on the unused borrowing capacity, which varies by facility.
[3]	On January 17, 2014, we completed the issuance of $600,000 of one-year and $200,000 of three-years term notes. On June 18, 2014, we completed the issuance of $400,000 of four-year term notes, of which we retained $37,000.
[4]	The weighted average interest rate at September 30, 2014, was 1.80%. We pay interest monthly.
[5]	The amortization date is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the due date for all outstanding balances. After the amortization date, all collections that represent the repayment of Match funded advances pledged to the facilities must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.
[6]	On July 16, 2014, we entered into agreements to extend the amortization dates of our Series 2012 variable funding notes to August 28, 2015.
[7]	On February 14, 2014, the Series 2013 variable funding notes were amended to extend the amortization and maturity dates by one year and to reduce the interest rate spreads compared to December 31, 2013.

Match_Funded_Liabilities_Paren

Match Funded Liabilities (Parenthetical) (Detail) (USD $)	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Jan. 17, 2014	Jan. 17, 2014	Jun. 18, 2014	Jun. 18, 2014	Sep. 30, 2014	Jun. 24, 2014
		Minimum	Maximum	One-Year Term Notes	Three-Year Term Notes	Four-Year Term Notes	Four-Year Term Notes	Variable Interest Entity	Variable Interest Entity
								Series 2014 T3 Term Notes	Series 2014 T3 Term Notes
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'
Weighted average interest rate	1.80%	'	'	'	'	'	'	'	'
Percentage of fee on the unused borrowing	'	0.50%	0.63%	'	'	'	'	'	'
Debt instrument issuance	'	'	'	$600,000,000	$200,000,000	'	$400,000	$37,000,000	$37,000,000
Maturity period for note	'	'	'	'1 year	'3 years	'4 years	'	'	'

Match_Funded_Liabilities_Analy

Match Funded Liabilities - Analysis of Borrowing by Maturity (Detail) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Analysis of Borrowing by Expected Maturity:	'
2014	$0	[1]
2015	3,507,636	[1]
2016	850,000	[1]
2017	675,000	[1]
2018 and thereafter	513,000	[1]
Total	$5,545,636	[1]
[1]	(1)The expected maturity date is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.

Other_Borrowings_Detail

Other Borrowings (Detail) (USD $)	Sep. 30, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'		'
Weighted average interest rate for other borrowings	3.43%		'
Other borrowings	$1,093,837		$343,386
Senior Secured Term Loan Facility	'		'
Debt Instrument [Line Items]	'		'
Other borrowings	341,324	[1]	343,386	[2]
EBO Facility	'		'
Debt Instrument [Line Items]	'		'
Other borrowings	452,258	[3]	0	[3]
RPL Facility	'		'
Debt Instrument [Line Items]	'		'
Other borrowings	274,306	[4]	0	[4]
Note Facility	'		'
Debt Instrument [Line Items]	'		'
Other borrowings	$25,949	[5]	$0	[5]
[1]	Under our advance funding facilities, we are contractually required to remit collections of Match funded advances to the trustee within two days of receipt. We do not use the collected funds to reduce the related Match funded liabilities until the payment dates specified in the indenture. The balance also includes amounts that we set aside to provide for possible shortfalls in the funds available to pay certain expenses and interest. Lastly, this balance includes collections on our Loans held for investment of $7,672, which will be used to pay down a portion of our Other borrowings on the first funding date following quarter end.
[2]	On June 27, 2013, we entered into a $350,000 senior secured term loan facility, which was issued at a discount to par. The senior secured term loan facility has a maturity date of June 27, 2020 and an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor. As of September 30, 2014, the interest rate on our senior secured term loan facility was 4.50%.
[3]	On March 3, 2014, we entered into the EBO Facility to finance the purchase of our GNMA EBO loans. The facility has a maturity date of March 2, 2015 and an interest rate of 1-Month LIBOR plus 305 bps.
[4]	On June 26, 2014, we entered into the RPL Facility to finance the purchase of our RPLs. The facility has a maturity date of December 26, 2014 and an interest rate of 1-Month LIBOR plus 250 bps.
[5]	On June 24, 2014, we entered into the Note Facility to partially finance the purchase of $37,000 of notes retained as part of the Series 2014 T3 Term Note issuance on June 18, 2014. The Note Facility matures monthly with a next maturity date of October 23, 2014. The Note Facility has an interest rate of 1-Month LIBOR plus 115 bps.

Other_Borrowings_Parenthetical

Other Borrowings (Parenthetical) (Detail) (USD $)

Sep. 30, 2014

Dec. 31, 2013

Jun. 27, 2013

Sep. 30, 2014

Dec. 31, 2013

Jun. 27, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Jun. 24, 2014

Sep. 30, 2014

Dec. 31, 2013

Mar. 03, 2014

Jun. 26, 2014

Jun. 27, 2013

Sep. 30, 2014

Jun. 27, 2013

Jun. 24, 2014

Mar. 03, 2014

Jun. 26, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Jun. 24, 2014

Senior Secured Term Loan Facility

Senior Secured Term Loan Facility

Senior Secured Term Loan Facility

Senior Secured Term Loan Facility

EBO Facility

EBO Facility

RPL Facility

RPL Facility

Note Facility

Note Facility

Note Facility

Revolving Credit Facility

Revolving Credit Facility

Base Rate

LIBOR

LIBOR

LIBOR

LIBOR

LIBOR

Variable Interest Entity

Variable Interest Entity

Variable Interest Entity

Variable Interest Entity

EBO Facility

RPL Facility

Senior Secured Term Loan Facility

Senior Secured Term Loan Facility

Note Facility

Revolving Credit Facility

Revolving Credit Facility

Series 2014 T3 Term Notes

Series 2014 T3 Term Notes

EBO Facility

RPL Facility

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument face amount

'

'

'

'

'

$350,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$37,000,000

$37,000,000

Debt instrument, maturity date

'

'

27-Jun-20

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1-Jun-48

[1],[2]

'

Interest rate, description

'

'

'an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor

'

'

'

'

'

'

'

'1-Month LIBOR

'

'

'1-Month LIBOR

'1-Month LIBOR

'

'

'

'

'

'

'

'

'281 bps

[1],[3]

'

Percentage added for interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.50%

3.50%

'

1.15%

3.05%

2.50%

'

'

'

'

Floor of LIBOR

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

Debt instrument, interest rate

'

'

'

4.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt instrument carrying amount

$1,093,837,000

$343,386,000

'

$341,324,000

[4]

$343,386,000

[5]

'

$452,258,000

[6]

$0

[6]

$274,306,000

[7]

$0

[7]

'

$25,949,000

[8]

$0

[8]

'

'

'

'

'

'

'

'

$726,565,000

[9]

$0

[9]

'

'

[1]

Each term note and variable funding note issuance has four classes, an A, B, C, and D class, with the exception of the Series 2014 T3 Term Notes which have only an A and B class. The Series 2014 T3 Class B Term Notes may be exchanged for notes in three separate classes: BX, CX and DX.

[2]

The amortization date is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the due date for all outstanding balances. After the amortization date, all collections that represent the repayment of Match funded advances pledged to the facilities must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.

[3]

The weighted average interest rate at September 30, 2014, was 1.80%. We pay interest monthly.

[4]

Under our advance funding facilities, we are contractually required to remit collections of Match funded advances to the trustee within two days of receipt. We do not use the collected funds to reduce the related Match funded liabilities until the payment dates specified in the indenture. The balance also includes amounts that we set aside to provide for possible shortfalls in the funds available to pay certain expenses and interest. Lastly, this balance includes collections on our Loans held for investment of $7,672, which will be used to pay down a portion of our Other borrowings on the first funding date following quarter end.

[5]

On June 27, 2013, we entered into a $350,000 senior secured term loan facility, which was issued at a discount to par. The senior secured term loan facility has a maturity date of June 27, 2020 and an interest rate of 1-Month LIBOR plus 350 bps, with a 1.00% LIBOR floor. As of September 30, 2014, the interest rate on our senior secured term loan facility was 4.50%.

[6]

On March 3, 2014, we entered into the EBO Facility to finance the purchase of our GNMA EBO loans. The facility has a maturity date of March 2, 2015 and an interest rate of 1-Month LIBOR plus 305 bps.

[7]

On June 26, 2014, we entered into the RPL Facility to finance the purchase of our RPLs. The facility has a maturity date of December 26, 2014 and an interest rate of 1-Month LIBOR plus 250 bps.

[8]

On June 24, 2014, we entered into the Note Facility to partially finance the purchase of $37,000 of notes retained as part of the Series 2014 T3 Term Note issuance on June 18, 2014. The Note Facility matures monthly with a next maturity date of October 23, 2014. The Note Facility has an interest rate of 1-Month LIBOR plus 115 bps.

[9]

Other borrowings include the carrying value of our borrowings to acquire Loans held for investment. See Note 8 for more information about our Other borrowings.

Other_Borrowings_Analysis_of_B

Other Borrowings - Analysis of Borrowing by Maturity - Senior Secured Term Loan Facility (Detail) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Analysis of Other Borrowing by Expected Repayment Date:	'
2014	$301,130	[1]
2015	455,758	[1]
2016	3,500	[1]
2017	3,500	[1]
2018 and thereafter	334,250	[1]
Total	1,098,138	[1],[2]
Ordinary issuance discount balance	$4,301
[1]	The EBO Facility, the RPL Facility and the Note Facility expected payment dates are based on the current outstanding balance and maturity date of these facilities.
[2]	On March 3, 2014, we entered into the EBO Facility to finance the purchase of our GNMA EBO loans. The facility has a maturity date of March 2, 2015 and an interest rate of 1-Month LIBOR plus 305 bps.

Ordinary_Shares_Increases_in_N

Ordinary Shares - Increases in Number of Ordinary Shares (Detail)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Common Stock, Number of Shares [Roll Forward]	'	'
Ordinary shares issued - beginning balance	71,016,771	55,884,718
Issuance of new ordinary shares	0	15,132,053
Ordinary shares issued - ending balance	71,016,771	71,016,771

Ordinary_Shares_Additional_Inf

Ordinary Shares - Additional Information (Detail) (USD $)	9 Months Ended		0 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Jun. 26, 2013	Jan. 22, 2013	Jun. 26, 2013
			Underwriters Exercise Of Overallotment Option	Underwriters Exercise Of Overallotment Option	Additional Issuances
					Underwriters Exercise Of Overallotment Option
Subsidiary, Sale of Stock [Line Items]	'	'	'	'	'
Number of ordinary shares issued	0	15,132,053	13,000,000	970,578	1,161,475
Net proceeds from over allotment exercise	$0	$334,390	$315,918	$17,633	'
Proceeds from additional shares issued to underwriters	'	$333,536	$325,714	'	'

Earnings_Per_Share_Additional_

Earnings Per Share - Additional Information (Details) (USD $)	3 Months Ended				9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]	'		'		'		'
Net income	$49,214		$39,166		$164,234		$111,077
Weighted average ordinary shares outstanding	71,016,771		71,016,771		71,016,771		61,812,369
Weighted average potential dilutive ordinary shares	1,771		0		0		0
Average diluted ordinary shares	71,018,542		71,016,771		71,016,771		61,812,369
Basic earnings per share (usd per share)	$0.69		$0.55		$2.31		$1.80
Diluted earnings per share (usd per share)	$0.69		$0.55		$2.31		$1.80
Stock Options	'		'		'		'
Stock options excluded from the computation of diluted EPS:	'		'		'		'
Anti-dilutive (shares)	465,000	[1]	0	[1]	515,000	[1]	0	[1]
Market-Based Options	'		'		'		'
Stock options excluded from the computation of diluted EPS:	'		'		'		'
Market-based (shares)	515,000	[2]	0	[2]	515,000	[2]	0	[2]
[1]	These stock options were anti-dilutive because their exercise price was greater than the average market price of our stock.
[2]	Shares that are issuable upon the achievement of certain performance criteria related to our stock price and an annualized rate of return to investors. Note 14 provides details of our share-based compensation.

Derivative_Financial_Instrumen2

Derivative Financial Instruments - Additional Information (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014
In Thousands, unless otherwise specified	Cash Flow Hedging	Cash Flow Hedging	Interest Rate Swap
Derivatives, Fair Value [Line Items]	'	'	'
Interest rate swaps to hedge against the effects of a change	'	'	'1-Month LIBOR
Cash collateral right to reclaim of hedge agreements	$1,075	$1,075	'
Cash collateral obligated to return of hedge agreements	$2,820	$3,500	'

Derivative_Financial_Instrumen3

Derivative Financial Instruments - Interest Rate Swaps (Detail) (USD $)	9 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Derivatives, Fair Value [Line Items]	'		'
Total asset derivatives, Notional Amount	$449,925		$515,065
Total asset derivatives, Fair Value	2,871		3,835
Total liability derivatives, Notional Amount	86,358		438,130
Total liability derivatives, Fair Value	-229		-529
Designated as Hedges	'		'
Derivatives, Fair Value [Line Items]	'		'
Total asset derivatives, Notional Amount	449,925		515,065
Total liability derivatives, Notional Amount	86,358		438,130
Total asset derivatives, Fair Value	2,871		3,835
Total liability derivatives, Fair Value	-229		-529
Designated as Hedges | Other Assets | Interest Rate Swap 2	'		'
Derivatives, Fair Value [Line Items]	'		'
Date Opened	15-May-12	[1],[2]	'
Effective Date	15-May-12	[1],[2],[3]	'
Maturity	15-May-16	[1],[2]	'
We Pay	0.61%	[1],[2]	'
We Receive	'1-Month LIBOR	[1],[2]	'
Total asset derivatives, Notional Amount	19,795	[1],[2]	'
Total asset derivatives, Fair Value	7	[1],[2]	'
Designated as Hedges | Other Assets | Interest Rate Swap 3	'		'
Derivatives, Fair Value [Line Items]	'		'
Date Opened	15-Sep-12	[1],[2]	15-Sep-12	[1]
Effective Date	15-Sep-12	[1],[2],[3]	15-Sep-12	[1],[3]
Maturity	15-Aug-17	[1],[2]	15-Aug-17	[1]
We Pay	0.52%	[1],[2]	0.52%	[1]
We Receive	'1-Month LIBOR	[1],[2]	'1-Month LIBOR	[1]
Total asset derivatives, Notional Amount	92,121	[1],[2]	177,056	[1]
Total asset derivatives, Fair Value	1,767	[1],[2]	1,084	[1]
Designated as Hedges | Other Assets | Interest Rate Swap 5	'		'
Derivatives, Fair Value [Line Items]	'		'
Date Opened	15-Jan-13	[1],[2]	15-Jan-13	[1]
Effective Date	15-Jan-16	[1],[2],[3]	15-Jan-16	[1],[3]
Maturity	15-Dec-17	[1],[2]	15-Dec-17	[1]
We Pay	1.40%	[1],[2]	1.40%	[1]
We Receive	'1-Month LIBOR	[1],[2]	'1-Month LIBOR	[1]
Total asset derivatives, Notional Amount	338,009	[1],[2]	338,009	[1]
Total asset derivatives, Fair Value	1,097	[1],[2]	2,751	[1]
Designated as Hedges | Other Liabilities | Interest Rate Swap 1	'		'
Derivatives, Fair Value [Line Items]	'		'
Date Opened	15-Mar-12	[1],[2]	15-Mar-12	[1]
Effective Date	15-Mar-12	[1],[2],[3]	15-Mar-12	[1],[3]
Maturity	15-Mar-16	[1],[2]	15-Mar-16	[1]
We Pay	0.63%	[1],[2]	0.63%	[1]
We Receive	'1-Month LIBOR	[1],[2]	'1-Month LIBOR	[1]
Total liability derivatives, Notional Amount	86,358	[1],[2]	102,522	[1]
Total liability derivatives, Fair Value	-229	[1],[2]	-364	[1]
Designated as Hedges | Other Liabilities | Interest Rate Swap 2	'		'
Derivatives, Fair Value [Line Items]	'		'
Date Opened	'		15-May-12	[1]
Effective Date	'		15-May-12	[1],[3]
Maturity	'		15-May-16	[1]
We Pay	'		0.61%	[1]
We Receive	'		'1-Month LIBOR	[1]
Total liability derivatives, Notional Amount	'		28,565	[1]
Total liability derivatives, Fair Value	'		-25	[1]
Designated as Hedges | Other Liabilities | Interest Rate Swap 4	'		'
Derivatives, Fair Value [Line Items]	'		'
Date Opened	'		15-Jan-13	[1]
Effective Date	'		15-Jan-14	[1],[3]
Maturity	'		15-Jul-14	[1]
We Pay	'		0.34%	[1]
We Receive	'		'1-Month LIBOR	[1]
Total liability derivatives, Notional Amount	'		307,043	[1]
Total liability derivatives, Fair Value	'		($140)	[1]
[1]	There was an unrealized pre-tax gain of $1,341 and an unrealized pre-tax loss of $664 related to our interest rate swaps included in AOCI for the three and nine months ended September 30, 2014, respectively. There was an unrealized pre-tax loss of $1,592 and an unrealized pre-tax gain of $3,761 related to our interest rate swaps included in AOCI for the three and nine months ended September 30, 2013, respectively. Given the current and expected effectiveness of our hedging arrangements, we do not expect any reclassifications from AOCI into earnings associated with hedging ineffectiveness related to these hedging arrangements during the next twelve months.
[2]	Projected net settlements for the next twelve months total approximately $633 of payments to the counterparty.
[3]	The effective date of the swap is the date from which monthly net settlements begin to be computed.

Derivative_Financial_Instrumen4

Derivative Financial Instruments - Interest Rate Swaps (Parenthetical) (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'	'	'	'
Projected cash flow hedge	$633	'	$633	'
Unrealized gains (losses) related to interest rate swap included in other comprehensive income	$1,341	$1,592	($664)	$3,761

Derivative_Financial_Instrumen5

Derivative Financial Instruments - Summarization of Use of Derivative (Detail) (Interest Rate Swap, USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Interest Rate Swap	'	'
Derivatives, Notional Disclosures [Roll Forward]	'	'
Notional beginning balance	$953,195	$414,631
Additions	0	645,052
Maturities	-71,122	0
Terminations	0	0
Amortization	-345,790	-67,898
Notional ending balance	$536,283	$991,785

Interest_Income_Calculation_of

Interest Income - Calculation of Interest Income on Notes Receivable (Detail) (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Other Income and Expenses [Abstract]	'		'		'		'
Servicing fees collected	$177,113		$200,838		$551,960		$431,795
Subservicing fee payable to Ocwen	-83,634		-102,040		-265,179		-214,587
Net servicing fees retained by HLSS	93,479	[1]	98,798	[1]	286,781	[1]	217,208	[1]
Reduction in Notes receivable – Rights to MSRs	-10,617		-17,763		-14,807		-25,102
Servicing transfers	1,988	[2]	0	[2]	1,988	[2]	0	[2]
Increase (decrease) in the fair value of Notes receivable – Rights to MSRs	0		-2,588		0		0
Total	$84,850		$78,447		$273,962		$192,106
[1]	Net servicing fees retained by HLSS are included in the Interim Condensed Consolidated Statements of Operations as a component of Interest income. See Note 12 for additional information regarding our Interest income.
[2]	Ocwen is required to reimburse us in the event of a transfer of servicing at predetermined contractual rates.

Interest_Income_Other_Detail

Interest Income - Other (Detail) (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Interest and Other Income [Line Items]	'		'		'		'
Interest income other	$12,118		$697		$22,869		$896
Loan Interest	'		'		'		'
Interest and Other Income [Line Items]	'		'		'		'
Interest income other	9,811	[1]	0	[1]	17,365	[1]	0	[1]
Advance Financing Interest	'		'		'		'
Interest and Other Income [Line Items]	'		'		'		'
Interest income other	989	[2]	0	[2]	2,143	[2]	0	[2]
Bank Account Interest	'		'		'		'
Interest and Other Income [Line Items]	'		'		'		'
Interest income other	$1,318		$697		$3,361		$896
[1]	Represents interest earned at the stated note rate on each individual GNMA EBO loan, net of the amortization of the purchase premium on our GNMA EBO and other loans using the interest method of accounting, and the accretion of the accretable yield on our pools of RPLs using the interest method of accounting.
[2]	Represents interest earned on servicing advance financing we provided to Ocwen.

Interest_Expense_Detail

Interest Expense (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Interest Expense [Abstract]	'	'	'	'
Match funded liabilities	$28,580	$27,108	$82,536	$57,793
Other borrowings	9,732	4,214	23,016	4,423
Amortization of debt issuance costs	5,600	4,426	15,160	11,113
Interest rate swaps	234	332	946	1,027
Interest expense	$44,146	$36,080	$121,658	$74,356

Sharebased_Compensation_Additi

Share-based Compensation - Additional Information (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Aggregate shares authorized under the Plan	2,000,000	'	'
Forfeiture rate	4.00%	'	'
Weighted-average grant-date fair value of options (in dollars per share)	$0.75	'	'
Unrecognized compensation expense related to non-vested share option awards	$600,000	'	'
Awards outstanding	1,030,000	0	'
Dividend payments expense	$0	'	'
Outstanding, weighted average remaining contractual term	'3 years 1 month 24 days	'	'
Vested shares	0	'	0
Service-Based Options	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Expiration period after date of grant or termination of service	'10 years	'	'
Awards outstanding	515,000	'	'
Market-Based Options	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Expiration period after date of grant or termination of service	'10 years	'	'
Awards outstanding	515,000	'	'
Required percentage of strike price to vest	125.00%	'	'
Annualized rate of return for vesting criteria	12.50%	'	'
Market-Based Options | Immediately On The First Date As Of Which Both Of The Market-Based Criteria Have Been Met	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting percentage	25.00%	'	'
Market-Based Options | First Anniversary	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting percentage	25.00%	'	'
Market-Based Options | Second Anniversary	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting percentage	25.00%	'	'
Market-Based Options | Third Anniversary	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'
Vesting percentage	25.00%	'	'

Sharebased_Compensation_Fair_V

Share-based Compensation - Fair Value Assumptions (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Service-Based Options	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Risk-free interest rate	2.13%
Expected stock price volatility	19.62%
Expected dividend yield	7.82%
Expected option life (in years)	'6 years 6 months
Contractual life (in years)	'10 years
Service-Based Options | Minimum	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Fair Value	0.87
Service-Based Options | Maximum	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Fair Value	1.27
Market-Based Options	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Risk-free interest rate, minimum	0.13%
Risk-free interest rate, maximum	3.23%
Expected stock price volatility	19.62%
Expected dividend yield	7.82%
Contractual life (in years)	'10 years
Market-Based Options | Minimum	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected option life (in years)	'2 years 8 months 24 days
Fair Value	0.53
Market-Based Options | Maximum	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Expected option life (in years)	'3 years 6 months
Fair Value	1.43

Sharebased_Compensation_Option

Share-based Compensation - Option Activity (Details) (USD $)	9 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014		Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]	'		'
Outstanding at December 31, 2013	0		'
Granted	1,280,000		'
Exercised	0		'
Forfeited or expired	-250,000		'
Outstanding at September 30, 2014	1,030,000		0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]	'		'
Outstanding at December 31, 2013, weighted average exercise price per share	$0		'
Granted, weighted average exercise price per share	$22.90		'
Exercised, weighted average exercise price per share	$0		'
Forfeited or expired, weighted average exercise price per share	$23.12		'
Outstanding at June 30, 2014, weighted average exercise price per share	$22.85		$0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]	'		'
Outstanding, weighted average remaining contractual term	'9 years 2 months		'0 years
Outstanding, aggregate intrinsic value	$0	[1]	$0	[1]
Exercisable at September 30, 2014	0		'
Exercisable at June 30, 2014, weighted average exercise price per share	$0		'
Exercisable, weighted average remaining contractual term	'0 years		'
Exercisable, aggregate intrinsic value	$0	[1]	'
[1]	Intrinsic value represents the difference between the Company’s closing stock price and the exercise price multiplied by the number of options outstanding and exercisable at a price below that closing price.

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Effective income tax rate	0.00%	2.20%	0.00%	0.90%

Related_Party_Transactions_Tra

Related Party Transactions - Transactions with Ocwen under Purchase Agreement (Detail) (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Related Party Transactions [Abstract]	'		'		'		'
Servicing fees collected	$177,113		$200,838		$551,960		$431,795
Subservicing fee payable to Ocwen	-83,634		-102,040		-265,179		-214,587
Net servicing fees retained by HLSS	93,479	[1]	98,798	[1]	286,781	[1]	217,208	[1]
Servicing advances purchased from Ocwen in the ordinary course of business	$3,958,104		$3,590,458		$10,829,858		$5,111,443
[1]	Net servicing fees retained by HLSS are included in the Interim Condensed Consolidated Statements of Operations as a component of Interest income. See Note 12 for additional information regarding our Interest income.

Related_Party_Transactions_Add

Related Party Transactions - Additional Information (Detail) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

0 Months Ended

In Thousands, unless otherwise specified

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

1-May-14

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

1-May-14

Ocwen

Ocwen

Ocwen

Altisource

Altisource

Altisource

Altisource

Loan Interest

Loan Interest

Loan Interest

Loan Interest

Advance Financing Interest

LIBOR

LIBOR

Ocwen

Ocwen

Ocwen

Ocwen

Ocwen

Interest Income

Ocwen

Related Party Transaction [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Servicing advances purchase price

'

'

'

'

'

$20,157

'

'

'

'

'

'

'

'

'

'

'

'

Interest rate, description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1-month LIBOR

Servicing fees not yet remitted

'

'

'

'

5,837

[1]

'

8,482

[1]

'

'

'

'

'

'

'

'

'

'

'

Subservicing fee owed to Ocwen

'

'

'

'

5,860

[2]

'

8,114

[2]

'

'

'

'

'

'

'

'

'

'

'

Receivables from Ocwen

'

'

'

'

26,223

'

70,049

'

'

'

'

'

'

'

'

343

'

'

Interest income

'

'

'

'

'

'

'

'

'

'

'

989

0

2,143

0

'

'

'

Additional markup on actual cost incurred

'

'

'

'

15.00%

'

'

'

'

15.00%

'

'

'

'

'

'

'

'

Service fees with related parties

'

'

827

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Professional services fee earned

320

491

1,721

1,458

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Professional services fee incurred

$131

$30

$510

$90

'

'

'

$259

$178

$748

$530

'

'

'

'

'

'

'

Percentage added for interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.50%

0.55%

[1]

Ocwen is required to remit to us servicing fees it collects on our behalf within two business days. The amount due from Ocwen at September 30, 2014, represents servicing fees collected but not remitted at the end of the month. We record servicing fees we collect less the subservicing fee we pay to Ocwen less the reduction in Notes receivable – Rights to MSRs as Interest income as shown in Note 12.

[2]

The base fee and performance fee, if any, that comprise the subservicing fees payable are calculated and paid to Ocwen within three business days following the end of the month.

Related_Party_Transactions_Rec

Related Party Transactions - Receivable from and Payable to Related Parties (Detail) (USD $)	Sep. 30, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Related Party Transaction [Line Items]	'		'
Advance collections	$26,223		$70,049
Ocwen	'		'
Related Party Transaction [Line Items]	'		'
Servicing fees collected	5,837	[1]	8,482	[1]
Professional services	827	[2]	655	[2]
Advance collections	15,352	[3]	60,239	[3]
Receivable from servicing transfers	1,988	[4]	0	[4]
Other	2,219		673
Receivables from Ocwen	26,223		70,049
Subservicing fees payable	5,860	[5]	8,114	[5]
Professional services	290	[2]	354	[2]
Other	2,134		2,181
Payables to related party	8,284		10,649
Altisource	'		'
Related Party Transaction [Line Items]	'		'
Payables to related party	$233		$83
[1]	Ocwen is required to remit to us servicing fees it collects on our behalf within two business days. The amount due from Ocwen at September 30, 2014, represents servicing fees collected but not remitted at the end of the month. We record servicing fees we collect less the subservicing fee we pay to Ocwen less the reduction in Notes receivable – Rights to MSRs as Interest income as shown in Note 12.
[2]	The respective amounts are for professional services provided that were outstanding as of the dates indicated.
[3]	Upon collection, Ocwen is contractually obligated to remit Match funded advance collections to pay down our Match funded liabilities. This receivable represents the portion of Match funded advance collections that were in-transit to pay down our Match funded liabilities as of the dates indicated.
[4]	Ocwen is required to reimburse us in the event of a transfer of servicing at predetermined contractual rates.
[5]	The base fee and performance fee, if any, that comprise the subservicing fees payable are calculated and paid to Ocwen within three business days following the end of the month.

Related_Party_Transactions_Rec1

Related Party Transactions - Receivable from and Payable to Related Parties (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2014
Related Party Transaction [Line Items]	'
Period for related party to remit collections	'2 days
Ocwen	'
Related Party Transaction [Line Items]	'
Period to forward servicing fees collected on the Company's behalf by Ocwen	'3 days

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (USD $)	9 Months Ended			0 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Oct. 10, 2014	Oct. 16, 2014	Oct. 15, 2014	Sep. 30, 2014		Dec. 31, 2013
				Subsequent Event	Subsequent Event	Subsequent Event	EBO Facility		EBO Facility
Subsequent Event [Line Items]	'	'	'	'	'	'	'		'
Dividends paid, cash	$100,844,000	$75,478,000	'	$12,783,000	'	'	'		'
Cash dividend per share	'	'	'	$0.18	'	'	'		'
Other borrowings	1,093,837,000	'	343,386,000	'	'	'	452,258,000	[1]	0	[1]
EBO loans unpaid principal balance	'	'	'	'	'	$142,500,000	'		'
Monthly dividend declared	'	'	'	'	$0.18	'	'		'
[1]	On March 3, 2014, we entered into the EBO Facility to finance the purchase of our GNMA EBO loans. The facility has a maturity date of March 2, 2015 and an interest rate of 1-Month LIBOR plus 305 bps.

Restatement_Details

Restatement (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]	'	'	'	'	'	'
Notes receivable – Rights to MSRs	$618,962	'	$618,962	'	$633,769	'
All other assets	'	'	'	'	6,676,903	'
Total assets	7,952,345	'	7,952,345	'	7,310,672	'
Total liabilities	6,675,073	'	6,675,073	'	6,094,225	'
Retained earnings	64,773	'	64,773	'	3,513	'
All other equity	'	'	'	'	1,212,934	'
Total equity	1,277,272	1,241,309	1,277,272	1,241,309	1,216,447	873,379
Total liabilities and equity	7,952,345	'	7,952,345	'	7,310,672	'
Income Statement [Abstract]	'	'	'	'	'	'
Interest income – notes receivable – Rights to MSRs	84,850	78,447	273,962	192,106	'	'
Interest income – other	12,118	697	22,869	896	'	'
Total interest income	96,968	79,144	296,831	193,002	'	'
Related party revenue	320	491	1,721	1,458	'	'
Total revenue	97,288	79,635	298,552	194,460	'	'
Operating expenses	3,914	3,612	12,646	8,211	'	'
Income from operations	93,374	76,023	285,906	186,249	'	'
Other expense	'	'	'	'	'	'
Interest expense	44,146	36,080	121,658	74,356	'	'
Total other expense	44,146	36,080	121,658	74,356	'	'
Income before income taxes	49,228	39,943	164,248	111,893	'	'
Income tax expense	14	777	14	816	'	'
Net income	49,214	39,166	164,234	111,077	'	'
Earnings per share	'	'	'	'	'	'
Basic earnings per share (usd per share)	$0.69	$0.55	$2.31	$1.80	'	'
Diluted earnings per share (usd per share)	$0.69	$0.55	$2.31	$1.80	'	'
Statement of Comprehensive Income [Abstract]	'	'	'	'	'	'
Total other comprehensive income (loss), net of tax	731	-988	-585	2,742	'	'
Total comprehensive income	49,945	38,178	163,649	113,819	'	'
Statement of Cash Flows [Abstract]	'	'	'	'	'	'
All other operating cash flows	'	'	'	668,568	'	'
Net cash provided by operating activities	'	'	477,597	779,645	'	'
Reduction in Notes receivable – Rights to MSRs	'	'	14,807	25,102	'	'
All other investing cash flows	'	'	'	-3,879,789	'	'
Net cash used in investing activities	'	'	-900,965	-3,854,687	'	'
Net cash provided by financing activities	'	'	465,632	3,075,826	'	'
Net increase in cash	'	'	42,264	784	'	'
Cash at beginning of period	'	'	87,896	76,048	'	'
Cash at end of period	130,160	76,832	130,160	76,832	'	'
As Previously Reported	'	'	'	'	'	'
Statement of Financial Position [Abstract]	'	'	'	'	'	'
Notes receivable – Rights to MSRs	'	'	'	'	651,060	'
All other assets	'	'	'	'	6,676,903	'
Total assets	'	'	'	'	7,327,963	'
Total liabilities	'	'	'	'	6,094,225	'
Retained earnings	'	'	'	'	20,804	'
All other equity	'	'	'	'	1,212,934	'
Total equity	'	'	'	'	1,233,738	'
Total liabilities and equity	'	'	'	'	7,327,963	'
Income Statement [Abstract]	'	'	'	'	'	'
Interest income – notes receivable – Rights to MSRs	'	74,204	'	168,626	'	'
Interest income – other	'	697	'	896	'	'
Total interest income	'	74,901	'	169,522	'	'
Related party revenue	'	491	'	1,458	'	'
Total revenue	'	75,392	'	170,980	'	'
Operating expenses	'	3,612	'	8,211	'	'
Income from operations	'	71,780	'	162,769	'	'
Other expense	'	'	'	'	'	'
Interest expense	'	36,080	'	74,356	'	'
Total other expense	'	36,080	'	74,356	'	'
Income before income taxes	'	35,700	'	88,413	'	'
Income tax expense	'	777	'	816	'	'
Net income	'	34,923	'	87,597	'	'
Earnings per share	'	'	'	'	'	'
Basic earnings per share (usd per share)	'	$0.49	'	$1.42	'	'
Diluted earnings per share (usd per share)	'	$0.49	'	$1.42	'	'
Statement of Comprehensive Income [Abstract]	'	'	'	'	'	'
Total other comprehensive income (loss), net of tax	'	-988	'	2,742	'	'
Total comprehensive income	'	33,935	'	90,339	'	'
Statement of Cash Flows [Abstract]	'	'	'	'	'	'
All other operating cash flows	'	'	'	668,568	'	'
Net cash provided by operating activities	'	'	'	756,165	'	'
Reduction in Notes receivable – Rights to MSRs	'	'	'	48,582	'	'
All other investing cash flows	'	'	'	-3,879,789	'	'
Net cash used in investing activities	'	'	'	-3,831,207	'	'
Net cash provided by financing activities	'	'	'	3,075,826	'	'
Net increase in cash	'	'	'	784	'	'
Cash at beginning of period	'	'	'	76,048	'	'
Cash at end of period	'	76,832	'	76,832	'	'
Adjustments	'	'	'	'	'	'
Statement of Financial Position [Abstract]	'	'	'	'	'	'
Notes receivable – Rights to MSRs	'	'	'	'	-17,291	'
All other assets	'	'	'	'	0	'
Total assets	'	'	'	'	-17,291	'
Total liabilities	'	'	'	'	0	'
Retained earnings	'	'	'	'	-17,291	'
All other equity	'	'	'	'	0	'
Total equity	'	'	'	'	-17,291	'
Total liabilities and equity	'	'	'	'	-17,291	'
Income Statement [Abstract]	'	'	'	'	'	'
Interest income – notes receivable – Rights to MSRs	'	4,243	'	23,480	'	'
Interest income – other	'	0	'	0	'	'
Total interest income	'	4,243	'	23,480	'	'
Related party revenue	'	0	'	0	'	'
Total revenue	'	4,243	'	23,480	'	'
Operating expenses	'	0	'	0	'	'
Income from operations	'	4,243	'	23,480	'	'
Other expense	'	'	'	'	'	'
Interest expense	'	0	'	0	'	'
Total other expense	'	0	'	0	'	'
Income before income taxes	'	4,243	'	23,480	'	'
Income tax expense	'	0	'	0	'	'
Net income	'	4,243	'	23,480	'	'
Earnings per share	'	'	'	'	'	'
Basic earnings per share (usd per share)	'	$0.06	'	$0.38	'	'
Diluted earnings per share (usd per share)	'	$0.06	'	$0.38	'	'
Statement of Comprehensive Income [Abstract]	'	'	'	'	'	'
Total other comprehensive income (loss), net of tax	'	0	'	0	'	'
Total comprehensive income	'	4,243	'	23,480	'	'
Statement of Cash Flows [Abstract]	'	'	'	'	'	'
All other operating cash flows	'	'	'	0	'	'
Net cash provided by operating activities	'	'	'	23,480	'	'
Reduction in Notes receivable – Rights to MSRs	'	'	'	-23,480	'	'
All other investing cash flows	'	'	'	0	'	'
Net cash used in investing activities	'	'	'	-23,480	'	'
Net cash provided by financing activities	'	'	'	0	'	'
Net increase in cash	'	'	'	0	'	'
Cash at beginning of period	'	'	'	0	'	'
Cash at end of period	'	$0	'	$0	'	'